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INTRODUCTION 
Deranged carbohvdrate homeostasis as manifest in pro-
gressive hypoglycemia is a significant feature in the path-
ogenesis of endotoxin shock. Insufficient glucose provision 
for energy metabolism contributes to organ dysfunction and 
circulatory collapse .v.rhich are the more appreciated hallmarks 
of shock pathology. Three basic mechanisms have been pro-
posed to account for the endotoxic defects in carbohydrate 
metabolism regulation: first, liver glycogen stores are rap-
idly released early in the onset of endotoxemia; second, he-
patic gluconeogenesis is depressed; and lastly, glucose up-
take and utilization by peripheral tissues are significant-
ly enhanced in endotoxemia. 
Whereas glycogen mobilization is attributed to enhanced 
sympathetic activity, the depression of gluconeogenesis and 
enhanced glucose utilization have been recently associated 
with endotoxic hyperinsulinemia. Since glucocorticoids an-
tagonize the actions of insulin on carbohydrate metabolism, 
the present study evaluated glucocorticoid influences on var-
ious parameters of endotoxic glucose metabolism both in vivo 
· and in vitro. In particular, glucose hypercatabolism in the 
endotoxic epididymal fat pad was characterized and the mech-
anism of dexamethasone's influence on the enhanced glucose 
utilization was evaluated. 
1 
REVIE{'J OF LITERATURE 
Role of Altered Glucose Homeostasis in Endotoxin Shock 
The depletion of carbohydrate stores and ihability to 
maintain blood glucose levels are key metabolic lesions un-
derlying endotoxin lethality. As outlin~d in a rec~nt review 
by Hinshaw (29), the evidence for this relation of altered 
glucose homeostasis with the pathogenesis of endotoxin shock 
is of three types: (i) the loss of glycogen stores correl-
ates with the progression of shock and agents which maintain 
glycogen stores prevent lethality; (ii) hypoglycemia develops 
in a progressive manner and correlates with the cardiovascu-
lar decompensation of shock; and (iii) prevention of hypogly-
cemia either by extrinsic glucose infusion therapy or by in-
trinsic manipulation of the mechanisms regulating glucose lev-
els are generally beneficial to the organism and blunt the 
progression of shock. These three lines of evidence will now 
be considered. 
A. Glycogen Depletion and Endotoxin Shock 
Berry, Smythe, and Young (4) determined total body car-
bohydrate content in the carcasses of mice administered Salm • 
. typhimurium ip and found that at the time of death these mice 
retained an average of only 0.9 mg./gm. body weight of carbo-
hydrate as compared with control mice whose total body carbo-
hydrate averaged 6.5 mg./gm. Evaluation of liver glycogen 
2 
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levels in mice receiving identical treatment revealed a mar-
ked depletion of these glycogen stores. Administration of 
the dose of endotoxin which was responsible for these alter-
ations in carbohydrate homeostasis resulted in almost 100% 
lethality. Comparable results were obtained by Menten and 
Manning (43) who reported hyperglycemia in rabbits adminis-
tered lethal doses of killed s~ enteriditis bacteria. Zeckwer 
and Goodell (70) correlated the initial hyperglycemic res-
ponse with glycogenolysis in a later study. Hamosh and 
Shapiro (27) reported enhanced liver glycogenolysis bv liver 
slices and homogenates prepared from rats treated with Chro-
mobacterium prodigiosum endotoxin. Liver glycogen depletion 
in fed mice administered lethal doses of E. coli or Shigella 
flexneri endotoxin was documented by Sanford, Barnett, and 
Gott (54). 
Carbohydrate store depletion is generally reflected in 
the blood glucose changes characteristic of endotoxemia. With-
in an hour following endotoxin administration, a hyperglyce-
mia as described by Menten and Manning (43) results, followed 
by a hypoglycemia with blood glucose levels often essentially 
zero at the time of death. 
B. Hypoglycemia and Endotoxin Shock 
Endotoxin hypoglycemia has been documented by a number 
of investigators in several models. Berk (1) demonstrated two 
patterns of hypoglycemia in dogs receiving 0.25 to 2.0 mg./kg. 
E. coli endotoxin iv. While 58% of the dogs demonstrated an 
initial modest rise in lllood glucose (although not hyperglyce-
4 
mic) followed by a fall;in the remainder of the dogs, blood 
glucose levels fell steadily from the time of endotoxin admin-
istration. Berk (1) also reported hypoglycemia in the human 
patient with bacteremic shock and suggested that both glucose 
production and glucose utilization regulation may represent 
mechanisms whereby endotoxin affects blo~d glucose levels. 
Burrows (9) reported hyperglycemia followed by hypoglycemia 
in both the conscious and unconscious Shetland pony adminis-
tered ~· coli endotoxin iv. Griffiths, Groves, and Leung (25) 
demonstrated hypoglycemia in fasted dogs following the iv in-
jection of live ~· coli bacteria. Both McCallum and Berry (41) 
and Berry, Smythe and Young (4) reported the development of 
hypoglycemia iri mice administered ~· tvphimurium endotoxin ip. 
Finkelstein (22) reported a marked hypoglycemia follm,ring ad-
ministration of endotoxin to chick embryos. Filkins, Buchanan, 
and Cornell (21) demonstrated hypoglycemia in the rat treat-
ed with 5 mg. ~· enteriditis endotoxin iv. Spitzer et a.l. 
(62) documented hypoglycemia in the baboon (Papio cynoceph-
alus) injected with 4 to 5 mg./kg. ~· coli endotoxin iv. 
c. M.aintainence of Blood Glucose and Lethality Protection 
That hypoglycemia--and the depletion of carbohydrate 
stores which it represents--is an important metabolic lesion 
in the endotoxic animal was suggested in studies of McNamara, 
Mills, and Aaby (42). Endotoxic rabbits were maintained on 
one of three treatments: normal saline; 25% mannitol; or 
50% glucose. Glucose solution administration resulted in sig-
nificantly greater increases in mean blood pressure and pulse 
5 
pressure than administration of equivalent osmolar doses of 
saline or mannitol. Survival among the glucose-treated rab-
bits was also significantly greater. Berk (1) reported that 
maintenance of the blood glucose levels in his dogs receiv-
ing low doses of endotoxin significantly increased survival 
and commented that hypoglycemia is a factor which probably 
affects survival at all doses of endotoxin, but with larger 
doses, additional lethal factors play a key role as well. 
Hinshaw et al. (30) provide further evidence for the deleter-
ious effect of hypoglycemia in the endotoxic animal. Eight 
of eleven dogs treated with 1 mg./kg. of E. coli endotoxin 
died with marked hypoglycemia, while the remaining three main-
tained their blood glucose leve~s and survived. Nin~ ad-
ditional dogs were given iv 50% dextrose at rates sufficient 
to maintain blood glucose levels at control values, and all 
of these dogs survived. A positive correlation was shown to 
exist between endogenously maintained blood glucose levels 
and survival time. Exogenously administered glucose, in ad-
dition to maintaining blood glucose levels, was also found to 
improve additional metabolic, and certain cardiovascular pa-
rameters. Maintenance of adequate carbohydrate stores for 
energy metabolism thus can provide significant protection for 
the animal in shock~. 
Hechanisms Underly ing Altered Glucose Homeostasis 
Three contributory mechanisms have been delineated to 
account for inability of the endotoxic organism to maintain 
carbohydrate homeo~tasis. First, liver glycogen stores are 
depleted relatively rapidly. Second, a defect in hepatic 
gluconeogenesis results in a decreased output of glucose for 
the organism. Third, glucose uptake and utilization by per-
ipheral tissues are enhanced. Evidence exists to substan~ 
tiate each of these alterations in carbohydrate metabolism, 
and each will be considered in turn. 
A. Liver Glycogen Depl~tion 
The first characteristic alteration in carbohydrate 
metabolism, which occurs within a few hours following endo-
toxin administration to the animal, is rapid liver glyco-
6 
genolysis. Menten and Manning (43) reported a hyperglycemia 
in guinea pigs and rabbits with spontaneous Salmonella in-
fections. Zeckwer and Goodell (70) injected suspensions of 
killed gram-negative bacteria of several species (~. proteus; 
B. proteus vulgaris; B. coli communis; ~· patatyphosus ~; and 
B. paratyphosus ~) into male rabbits and followed the changes 
in blood sugar over a course of several hours. The possibil-
ity that sympathetic stimulation of the adrenals, resulting 
in glycogenolysis, served as the underlying mechanism for the 
hyperglycemia was tested by Evans and Zeckwer (17). ~· coli 
suspensions were injected into adrenalectomized rabbits; this 
resulted in hypoglycemia accompanied by convulsions and ul-
timately lethality. McCallum and Berry (41) demonstrated a 
significant tliminution of liver glycogen in fasted female mice 
administered a lethal dose of Salm.typhimurium endotoxin as 
early as one hour after treatment. In addition, liver glyco-
gen synthase activity was significantly decreased and the 
7 
incorporation of the 14c-label from glucose-u- 14c into liver 
glycogen was substantially impaired. McCallum and Berry (41) 
suggested that the reduction in carbohydrate synthetic abil-
ity served as a probable cause for rapid sugar loss during 
endotoxemia. Holper et al. (31) administered LD 25-LD 50 doses 
of endotoxin to baboons and were able to demonstrate that the 
initial endotoxic hyperglycemi~ was dose-related, and was fol-
lowed by a hypoglycemia correlated with the liver glycogen 
depletion. In a recent review by Stoner and Heath (65), how-
ever, it is noted that not all body glycogen stores become 
depleted in shock. Citing their own 1958 study, as well as 
the 1954 study of Cordier and Dessaux, they reported no change 
in brain levels of glycogen with the onset of shock, and a 
simultaneous increase in cardiac glycogen levels. Berry, 
Smythe, and Young (4) hav~ reported a significant diminution 
of muscle (abdominal body wall) glycogen in Salm. typhimurium 
treated mice. The seem~ng inaccessibility of some glycogen 
stores, concomitant with the rapid depletion of liver and mus-
cle glycogen thus represent a significant contribution to the 
deranged carbohydrate metabolism of .shock. 
B. Impaired Hepatic Gluconeogenesis 
Defective liver gluconeogenesis has been demonstrated 
in the endotoxic animal. LaNoue, Mason, and Daniels (35) e-
valuated gluconeogenesis from sodium pyruvate by liver slices 
from rats injected with an LD 50 dose of E. coli endotoxin. 
In addition, the activities of key gluconeogenic enzymes--
glucose-6 phosphatase, fructose~l,6 diphosphatase, and phos-
8 
phoenolpyruvate carboxykinase--were quantitated. Results in-
dicated an impairment in the overall rate of glucogenesis and 
significantly lowered glucose-6 phosphatase activity, while 
other enzyme activities appeared unaffected. Shands, Miller, 
Martin and Senterfitt (58) measured gluconeogenesis in BCG-
infected mice administered s. typhimurium. endotoxin in vivo 
following an intraperitoneal injection of sodium pyruvate and 
sodium pyruvate-2- 14c, and concluded that the major defect 
leading to endotoxic hypoglycemia is in glucose synthesis from 
noncarbohydrate sources as reflected by the failure of these 
animals to raise their blood glucose levels following a pyru-
vate load. Filkins, Bucha~an, and Cornell (21) demonstrated 
impaired gluconeogenesis in vivo in rats treated with 3 mg. 
s. enteriditis endotoxin by measuring both the hyperglycemic 
response of the rat to alanine loading and the conversion of 
14 1 . 14 1 . 't f 1 
· C-a an1ne to C-g ucose. An .:!:!!. v1 ro assessment o g uco-
neogenesis using isolated hepatocytes from rats treated with 
1 mg. of endotoxin with alanine, lactate, and pyruvate as 
substrates also revealed that gluconeogenesis was defective. 
McCallum and Berry (41) measured the incorporation of the 14c-
label from alanine-u- 14c and pyruvate-2- 14c into blood glu-
cose · and reported a substantial impairment in mice adminis-
tered s. typhimurium endotoxin. Evidence points to the in~ 
ability of the endotoxic organism to maintain blood glucose 
levels by the synthesis of glucose from appropriate metabolic 
precursors. Thus, after utilization of the glucose supplied 
by initial glycogenolysis, hypoglycemia may result. 
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c. Peripheral Glucose Hypercatabolism 
In addition to defective provision of glucose for per-
ipheral tissue utilization, an enhanced glucose uptake and 
oxidation by peripheral tissues have been reported, and serve 
as a third contributory mechanism underlying endotoxic hypo-
glycemia and depletion of carbohydrate stores. Of all three 
mechanisms, glucose hypercatabolism is the least well-inves-
tigated and documented. In an attempt to clarify the mech-
anism of the hypoglycemic activity of endotoxin, Shands, Miller, 
Martin, and Senterfitt (58) ruled out the possibility of an 
endotdxin-induced hypermetabolic state. In mice administered 
endotoxin, they were unable to demonstrate glucose hypercat-
14 
abolism as represented by C-glucose clearance from the blood 
over a 20-minute time course, or by 14co 2 recovery in vivo 
over a 60-minute time course. More recent investigations, 
however, have suggested that enhanced glucose uptake and u-
tilization do occur in the endotoxic animal. Buchanan and 
Filkins (8) reported significantly enhanced 14co2 recovery 1n 
Vivo, 
cose, 
14 following intraperitoneal administration of U- C-glu-
in endotoxic rats over a four hour time course; signi-
ficant enhancement was not observed until 150 minutes after 
14 
rats received the C-glucose. This latter finding may be 
helpful in interpreting the seemingly conflicting data 6£ Shands 
et al.: evidently a lag period must occur before glucose hy-
percatabolism is demonstrable. Enhanced glucose utilization 
by the non-hepatic splanchnic area in baboons, as reflected by 
significant lowering of blood glucose levels in the mesenteric 
10 
vasculature, as reported by Spitzer et al. (62). A doubling 
of oxidative glucose metabolism was documented in a canine 
experimental peritonitis model by Bierenbaum, Bova, and Moss 
(5). Enhanced glucose utilization has also been demonstrated 
to occur in septicemia. Long, Spencer, Kinney, and Geiger (38) 
reported that glucose utilization more than doubled in septi-
cemic men, while their total metabolic rates were only slight-
ly increased; a dramatic inctease in peripheral glUcose util-
ization in septicemic men was also demonstrated by Gump, Long, 
Killian, and Kinney (26). 
To date, few attempts have been made to localize spe-
cific tissue sites of the glucose hypercatabolism. Ryan, 
Blackburn, and Clowes (52) induced peritonitis in rats, then 
removed epididymal fat pads and diaphragms for an in vitro 
14 
evaluation of C-glucose oxidation. A threefold increase 
in glucose oxidation in fat pads from the rats with perito-
nitis, as compared to normal rats, with no concomitant change 
in diaphragm glucose oxidation was demonstrated. Drucker and 
Dekiewiet (15) reported significantly enhanced glucose uptake 
by hemidiaphragms of rats subjected to severe hemorrhagic 
shock. In contrast to the latter results, Chaudry, Sayeed, 
and Baue (11) were unable to demonstrate significant changes 
in glucose uptake by soleus muscle in rats after a hemorrhag-
ic shock procedure. These studies do not serve to provide a 
complete or conclusive definition as to which peripheral tis-
sues contribute to the glucose hypercatabolism which has been 
demonstrated 1n vivo. 
ll 
Influence of Glucocorticoids and Insulin on Endotoxin Lethal-
ity and Hypoglycemia 
The ability of endotoxin to enhance glucose uptake and 
utilization, and to inhibit gluconeogenesis has led investi-
gators. to describe its actions as "insulin-like." Insulin 
has indeed been shown to play critical role~ in the caloric 
homeostasis alterations which :occur in the endotoxic ~nimal. 
Since the metabolic actions of insulin in the normal animal 
can be antagonized by the adrenal glucocorticoids, it may be 
anticipated that glucocorticoids protect the endotoxic animal 
not only against the derangements in carbohydrate homeostasis, 
but against ensuing lethality as well. 
Glucocorticoid protection against lethality has been 
documented by several investigators. Jeffries and Wilkins (34) 
administered Amphenone B and metyrapone to suppress cortico-
steroid production in mice, and demonstrated a ten-fold in-
crease in susceptibility to endotoxin lethality. Injection 
of corticosterone, cortisone, and hydrocortisone provided mar-
ked protection in both endotoxin- and endotoxin-steroid in-
hibitor-treated mice. Marecki (40) demonstrated significant 
protection against ~- coli endotoxin in lead-sensitized BALB/c 
mice following administration of 6-alpha-methylprednisolone; 
such protection was found to be related to the time of admin-
istration of the methylprednisolone in relation to the endotoxin. 
Administration of hydrocortisone, prednisolone, or dexameth-
asone simultaneously with endotoxin was reported by Mills (44) 
to have a significant protective effect in mice, mortality 
12 
being reduced from 83% in control groups to 20-25% in treated 
groups at the optimum glucocorticoid dose level. Woodruff, 
caridis, Cuevas, Koizumi, and Fine (69) demonstrated gluco-
corticoid protection in a trauma endotoxic model--30% immer-
sion burn--in rabbits. Berry and Smythe (3) administered 
cortisone acetate to mice simultaneously ~vith either an LD 50 
or t\vice the LD 50 dose of endo,toxin, producing a significant 
reduction in lethality. Delaying the injection of cortisone 
l, 2, or 4 hours after that of endotoxin resulted in a loss 
of the lethality protection. The latter is in agreement with 
Marecki's data and is consistent with the hypothetical mech-
anism of glucocorticoid action which requires a definitive lag 
period of time, as a result of glucocorticoid-specific stim~ 
ulation of protein synthesis. Berry and Smythe (3) further 
demonstrated that inhibitors of protein synthesis--such as 
actinomycin D and 2-thiouracil--potentiated the lethal action 
of endotoxin and prevented the protective effect of cortisone. 
That adrenal cortical hormones must play a role in the response 
of the _organism to an endotoxic stress was also documented by 
Berry and Smythe (2). Cholesterol content of adrenal glands 
removed from endotoxic mice was nearly depleted, indicating 
a maximal response of the adrehals to endotoxin prior to their 
removal. 
Several mechanisms have been postulated for the protec-
tive action of the glucocorticoids. These mechanisms appear 
to center around the known glucocorticoid abilities to suppress 
the immune system, stabilize membranes, and contribute to 
13 
caloric homeostasis through their influence on carbohydrate 
metabolism. Spath, Gorczynski and Lefer (59) were unable to 
demonstr-ate significant effects of dexamethasone on the char-
acteristic splanchnic vasoconstriction of canine shock follow-
ing hemorrhage, nor could they demonstrate a direct inotropic 
action of methylprednisolone or dexamethasone on papillary 
muscles removed from hemorrhaged cats. Latour and Renaud (36) 
were able to demonstrate inhibition of blood rheology changes 
following administration of triamcinolone prior to a non-le-
thal dose of endotoxin in rats. Characteristic fluctuations 
in thrombocytosis, platelet adhesiveness, and clotting time, 
as well as falling albumin levels were reduced by administra-
tion of high doses of triamcinolone two hours prior to endo-
toxin. Reilly and Schayer (49) reported that administration 
of cortisol in normal mice resulted in increased histamine 
formation in the gut, with lowered histamine formation in most 
other tissues and marked excretion of histamine. Schumer, 
Obernolte, and Erve (57) evaluated plasma and peritoneal his-
tamine concentration in endotoxic and dexamethasone-treated 
endotoxic rats. Their results showed an increase in plasma 
and peritoneal exudate histamine in the endotoxic rat; simul-
taneous administration of dexamethasone decreased plasma his-
tamine below control levels, and reduced peritoneal exudate 
histamine 40%. Such changes may well be accounted for by ei-
ther decreased formation or enhanced excretion of histamine 
as noted by Reilly and Schayer. 
Stabilization of lysosomal membranes by glucocorticoids 
has been documented in shock models. Spath et al.· (59) re-
ported significantly higher levels of the lysosomal enzyme 
14 
beta glucuronidase in dogs subjected to hemorrhagic shock but 
not treated with methylprednisolone or dexamethasone. Lefer 
and Martin (37) noted a low level of myocardial depressant fac-
tor in hemorrhaged cats treated with cortlsol or dexamethasone 
and were able to demonstrate an inverse correlation between 
MDF activity and survival time. The lowered MDF was associ-
ated with the stabilization of lysosomal membranes: release 
of lysosomal proteases is postulated to result in the break-
down of plasma proteins, one or several of which may be MDF. 
Warren, Ferguson, and Wangensteen (68) were unable to demon-
strate lysosomal stabilization in endotoxic dogs treated with 
massive doses of methylprednisolone (30 mg./kg.). However, 
they were also unable to significantly protect against lethal-
ity with that dose; both the endotoxic and the endotoxic-
methylprednisolone treated groups (N=lO) had only one long-
range survivor. In an in vitro study by Ferguson, Warren, and 
Wangensteenr (20), lysosome suspensions from canine livers re~ 
leased significantly less cathepsin D following the addition 
of several glucocorticoids, providing further evidence for sta-
bilization of lysosomal membranes as a protective mechanism. 
Glucocorticoid influence on immune and ·inflammatory reactions 
has also been cited as a mechanism underlying their lethality 
protection. In a study by Fukuda and Hata (23), antiendotoxic 
potencies of different glucocorticoids administered to endo-
toxic rats almost paralleled their respective anti-inflamrna-
15 
tory· potencies. As a more direct approach to this issue, 
Schumer, Erve, and Obernolte (56) evaluated complement fix-
' 
ation in an in vitro system to which ~· typhimurium endotoxin 
alone, or with dexamethasone, was added. They reported a 
dexamethasone-induced decrease in either complement levels 
or complement-fixation by endotoxin, and proposed that this 
would ultimately interfere with the production of anaphyla-
toxin or other shock toxins. 
Carbohydrate and liver metabolism changes induced by 
the glucocorticoids have been investigated; it may be antici-
pated that glucocorticoid mobilization of precursors to the 
liver for glucose synthesis as well as inhibition of glucose 
qptake and utilization would counteract the endotoxic deple-
tion of carbohydrate stores described above. The specific 
influence of adrenal corticosteroids on hepatic detoxification 
of endotoxin has not been extensively investigated. Filkins 
(as cited by Buchanan (6) ) demonstrated sensitization to en-
d6toxin-shock in adrenalectomized rats; however, liver homo-
genates from either acute or chronic adrenalectomized rats did 
not differ significantly from sham-operated controls in their 
ability to detoxify endotoxin as evaluated in the lead-sensi-
tized rat bioassay. In contrast, Woodruff et al. (69) repor-
ted that intravenous injections of corticosteroids in rabbits 
accelerated the clearance rate of endotoxins which were injec-
ted as well as those which entered from the intestine follow-
ing an ischemic injury. More conclusive results have been 
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obtained in regard to glucocorticoid influehce on hepatic car-
bohydrate metabolism. That glucocorticoids can significant-
ly protect against depletion of body carbohydrate stores was 
demonstrated by Berry, Smythe, and Young (4). Administration 
of 5 mg. cortisone to mice simultaneously with S. typhimurium 
endotoxin not only provided signLficant lethality protection 
but also markedly inhibited depletion of carbohydrate stores 
as represented by blood sugar, liver and muscle glycogen, and 
total body carbohydrates. Berry and Smythe further demonstra-
ted the specific ability of cortisone to influence hepatic 
enzyme levels in endotoxic mice (3). Endotoxin-poisoned mice 
showed normal levels of ·liver tryptophan pyrrolase activity 
if administered cortisone along with the endotoxin. Holtzman, 
et al. (32) assessed changes in key glycolytic intermediates 
in the liver from rats r~ceiving endotoxin, endotoxin plus 
dexamethasone, or saline. Administration of dexamethasone 
increased glycogen and blood glucose concentrations, decreased 
blood lactate levels, and returned liver fructose diphosphate 
and phosphoenolpyruvate levels to essentially control values, 
thus implicating a hepatic involvement of the glucocorticoids 
in maintainence of body carbohydrate stores. A similar study 
by Schuler, Erve, and Schumer (55) in endotoxin-shocked mon-
keys demonstrated, first, significant lethality protection by 
dexamethasone, and, second, the following changes in hepatic 
metabolite levels: increased glucose-6-phosphate, fructose-
6-phosphate, phosphoenotpyruvate, ATP, ADP and glycogen; and 
decreased fructose-1,6-diphosphate, lactate and AMP. All 
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metabolite levels were returned to essentially control lev-
els. The possible influence of the glucocorticoids in inhib-
iting endotoxic glucose hypercatabolism has been evaluated 
by Buchanan (6) in vivo in endotoxic dexamethasone-treated 
14 
rats administered C-glucose. 14co 2 collection for four hours 
was significantly depressed, thus reflecting a depression of 
endotoxin-induced glucose hypercatabolism; dexamethasone con-
comitantly ihhibited development of hypoglycemia in endotoxic 
rats (6). Thus, glucocorticoid administration can contribute 
to the maintenance of carbohydrate metabolism by influencing 
all three of the mechanisms which contribute to carbohydrate 
depletion as discussed previously. 
The actions of endotoxin on hepatic gluconeogenesis and 
peripheral glucose utilization can be said to be "insulin-
like." The possibility that insulin levels may be responsible 
for the alterations in carbohydrate metabolism and its regu-
lation which occur in endotoxic shock has been investigated. 
Actual elevations i.n endogenous insulin levels within the en-
dotoxic animal have been documented. Ryan, Blackburn, and 
Clowes (52) reported threefold higher insulin concentrations 
in their peritonitis rat model, which was assodiated with a 
threefold elevation of the insulin-sensitive adipose pyruvate 
dehydrogenase complex as well as the threefold increase in 
glucose oxidation to co 2 by epididymal fat pad fragments. 
Buchanan (6) demonstrated a long duration hyperinsulinemi~ 
(IRI) in response to endotoxin administration, and an ex.ag-
gerated insulin response to a glucose tolerance test (400 mg. 
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glucose ip) in the endotoxic rat. In addition, Buchanan and 
Filkins (7) demonstrated enhanced sensitization to endotoxin 
lethality in rats with administration of insulin, or with stim-
ulation of insulin secretion, such as administration of beta 
cell stimulants or glucose; fasting rats or administration of 
mannoheptulose--either of which treatment would lower endogen-
ous insulin levels--provided ~ignificant protection against 
endotoxin lethality. Spitzer et al. (63) reported enormous 
increases in plasma IRI levels in dogs administered an LD 70 
dose of E. coli endotoxin. The above data suggest that insulin 
is involved in the development of deranged carbohydrate homeo-
stasis in endotoxicosis. Since adrenal glucocorticoids can 
be considered "anti-insulin" in their metabolic actions, it 
might be anticipated from the results of previous investiga-
tions discussed above that they would have significant pro-
tective effects in the endotoxic animal. 
Endotoxic Adipose Tissue Metabolism 
Adipose tissue lipolysis in vitro and plasma lipid chan-
ges in vivo have been studied in order to delineate the role 
of adipose in the metabolism of the endotoxic animal. Printen, 
Keefe, Foster, and Brown (48). reported a significant rise in 
free fatty acid levels in dogs with endotoxemia, but not with 
hemorrhage. Since blood pressure changes in the hemorrhage 
model were regulated by the investigators so that pressure 
drops were equal in severity and rapidity with endotoxic dogs, 
they suggest that endotoxic alterations in adipose metabolism 
must be mediated through a more complex pathway than a simple 
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response to norepinephrine or epinephrine, released as a re-
sult of hypotension. Griffiths, Groves and Leung (25) repor-
ted a rise in plasma triglycerides associated with a rise in 
norepinephrine in dogs infused with live E. coli bacteria. 
Gallin, Kaye, and O'Leary (24) noted significant elevations 
in total serum lipids, free fatty acids, and triglycerides in 
patients with gram-negative ba6teremia. The enhanced lipoly-
sis which is found in endotoxic but not hemorrhagic shock, in 
spite of catecholamine release in both conditions may perhaps 
be explained by the results of Spitzer, Kovach, Rosell, Sandor, 
Spitzer and Storck (60). The norepinephrine-stimulated lipo-
lysis of isolated fat cells removed from several different de-
pots in the endotoxic dog was evaluated; endotoxic shock in 
vivo increased the norepinephrine-induced lipolytic response 
in subcutaneous, omental, and mesenteric fat cells as reflec-
ted by in vitro increased free fatty acid and glycerol release. 
Spitzer et al. ( 60 ). were also able to demonstrate a higher 
norepinephrine-stimulated lipolytic response from isolated 
canine fat cells inculliated with endotoxin in vitro. Assess-
ment of cAMP content in endotoxin-treated fat cells in the 
same system revealed that they had significantly higher cANP 
levels, which were then further elevated by subsequent nor-
epinephrine stimulation. Confirmation of the in vitro en-
hancement of adipose.cAMP levels by endotoxin comes from a 
study by Hewlett, Guerrant, Evans, and Greenough (28) which 
demonstrated enhanced responsiveness of epididymal fat cell 
membrane adenyl cyclase to epinephrine following in vitro 
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addition of E. coli endotoxin. Results from the studies 
summarized above do not seem to fit in with the concept of an 
insulin-like action on peripheral tissue metabolism; insulin 
inhibits lipolysis as well as lowering CAMP levels in the nor-
' mal adipocyte. To date, the only study assessing endotoxic 
glucose utilization by adipose is that of . Ryan, Blackburn, and 
Clowes (52) discussed above. How their results--significant 
glucose hypercatabolism by epididymal fat pad fragments--fit 
in with the well-documented endotoxic lipolysis by adipose 
has yet to be elucidated. 
Influence of Glucocorticoids and Insulin on Adipose Metabolism 
Although no specific investigations of the influence of 
the adrenal glucocorticoids or insulin on the metabolism of 
endotoxic adipose have been carried out, the influence of these 
two hormones on normal adipose tissue deserve some discuss-
ion: presumably they will exert the same qualitative influ-
ences over endotoxic adipose metabolism although quantitative 
differences may exist, as was documented by Spitzer in regard 
to norepinephrine sensitivity. Munck (46) reported a reduc-
tion in net glucose uptake by epididymal adipose isolated from 
adrenalectomized rats injected with cortisol, corticosterone, 
and deoxycorticosterone. The same steroids in vitro displayed 
similar actions, the effects occurring mainly after the adi-
pose incubation had proc~eded for over two hours. These re-
sults thus demonstrated that adipose can serve as a direct 
target for glucocorticoids. Fain, Scow, and Chernick (19) 
demonstrated enhanced fatty acid release fr.om rat adipose in-
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cubated in vitro with dekamethasone, corticosterone, or 2-
alpha-methylcortisol; again a 2~hour lag period was required 
before the glucocorticoids had any significant effects on li-
polysis. Addition . of insulin completely antagonized lipolysis. 
Further evidence for the apparent antagonism between the glu-
cocorticoids and insulin on glucose utili~ation is provided 
by Plager and Matsui (47). c6rtisol addition to an in vitro 
system of mouse ear epidermis significantly reduced metabolism 
of 14c-glucose to 14co 2 ; the cortisol effect could be com- · 
pletely antagonized by insulin at several different concentra-
tions. Treatment of isolated rat white fat cells with a max-
imally stimulating dose 6f insulin, in an incubation medium 
with a high concentration of glucose was reported by Czech and 
Fain (13) to completely antagonize the inhibitory action of 
d h 1 14 1 . 14 . examet asone on - C-D-g ucose convers1on to co 2 ; 1t was 
suggested that dexamethasone--or glucocorticoids in general--
inhibits glucose oxidation in the presence or absence of in-
sulin when transport of glucose into fat cells is rate-lim-
iting. In the latter situation, abundance of glucose and high 
insulin concentrations would assure the absence of any limita-
tions on the glucose transport process. Data supporting the 
direct interaction of insulin with superficial membrane struc-
tures of isolated fat cells was provided by Cuatrecasas (12); 
direct membrane interactions resulted in enhanced glucose u-
tilization and suppressed lipolysis. 
The above discussion of the actions of insulin and the 
glucocorticoids on adipose metabolism is in no way a complete 
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literature review of the extensive research in these areas. 
However, these results do provide sufficient insight into the 
effects of these hormones on normal metabolism in adipose 
tissue; perhaps one may extrapolate from these, and predict 
what influence the adrenal glucocorticoids and insulin may 
have on endotoxic adipose metabolism. 
Statement of Purpose 
The purposes of the following study were fourfold. First 
a systematic assessment of glucose oxidation by a number of 
endotoxic tissues was carried out in an attempt to define the 
specific tissue sites of glucose hypercatabolism which was dem-
onstrated in vivo. Second, the possibility that dexamethasone 
both in vi~o and in vitro may have a direct influence on endo-
to~ic epididymal adipose glucose utilization, in light of its 
ability to protect against lethality and hypoglycemia in en-
doto~icosis, was evaluated. Third, the ability of endotoxin 
in Vitro to induce glucose hypercatabolism by epididymal adi-
pose was assessed. Finally, the influence of insulin on en-
dotoxic adipose metabolism, and the possibility that it may 
mediate in vivo endotoxic glucose hypercatabolism was investi-
gated. 
METHODS 
A. Animals 
Animals used in lethality and all subsequent experi-
ments were male albino Holtzman rats (Holtzman Company, 
Madison, Wisconsin). Rats remained in the animal quarters 
I 
for approximately seven days post-shipment, and prior to 
experimental use in order to assure adjustment to animal 
quarter conditions of a 12-hour, light-dark cycle (light 
from 7 a.m. to 7 p.m.) and unlimited access to Puriria rat 
chow (Ralston Purina, St. Louis, f1issouri) and tap water. 
All rats were fasted overnight prior to experimentation; food 
was removed at 4 p.m. but access to water was permitted. 
B. Endotoxin 
Endotoxin used in all experiments was the Boivin prep-
aration of Salmonella enteriditis lipopolysaccharide (LPS), 
batch #505153 from Difco Laboratories, Detroit, Michigan. 
The lyophilized endotoxin was prepared in the appropriate con-
centration in pyrogen-free 0.9% saline (Baxter, Travenol Lab-
oratories Inc., Deerfield, Illinois). It was administered 
intravenously under light ether anesthesia by two routes. 
Large rats (approximately 280-320 grams and 70-80 days of age) 
as used in the lethality and hypoglycemia studies receive~ the 
endotoxin via the dorsal vein of the penis. Small rats (ap-
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proximately 90-110 grams and 26-30 days of age) as used in 
the 1n vivo and in vitro 14co collection studies received 
--- 2 
the endotoxin via a tail vein. Endotoxin concentrations were 
adjusted so that the larger rats received the appropriate 
dose in a total volume of l ml. of saline, whereas the smal-
ler rats received the appropriate dose in· a volume of 0.5 ml. 
of saline. 
C. De~amethasone 
Dexamethasone acetate (Sigma Laboratories, St. Louis, 
Missouri) was prepared in pyrogen-free saline in a concentra-
tion of 100 ~g./ml. and was dissolved by an electric magnetic 
stirring apparatus (Thermolyne, Sybron Corp., Dubuque, Iowa). 
The resulting suspension was then sonicated for 60 seconds 
with a Biosonik IV sonicator (Bronwill, Rochester, New York). 
The suspension was mixed by hand prior to each injection since 
some settling of dexamethasone would occur. l ml. was injec-
ted intraperitoneally in the abdominal region of the rat. 
D. Lethality P~otocols 
Fasted rats weighing 320+3 grams received l, 2, 4, or 8 
mg. of endotoxin iv and either l ml. saline or l ml. ( 100 ~g.) 
dexamethasone acetate ip. Both the iv endotoxin and the ap-
' propriate ip injectate were administered simultaneously under 
light ether (Anaesthesia Grade, Mallinckrodt, St. Louis, Mis-
souri). Ensuing leth~lity was followed for 48 hours, with 
rats living beyond 48 hours considered survivors. Most deaths 
occurred between 12 and 24 hours. All endotoxic-saline treat-
ed and endotoxic-dexaQethasone treated groups were run simul-
taneously on two separate occasions. 
1 
E. D~ta Analysis 
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Statistical analysis for significant differences was e-
valuated by the chi-square test with the correction factor of 
Yates for small samples. P-values for the comparison of appro-
priate chi-square values were obtained from a statistical ta-
ble (50). One degree of freedom was used in the analysis of 
this data. A p-value of less than 0.050 was considered sta-
tistically significant. 
Measurements of Plasma Glucose 
A. Glucose Analyzer 
Plasma glucose levels were determined by a glucose ana-
lyzer (Yellow Springs Instrument Hodel 23A). The analyzer 
permits r·eaction of glucose--as contained in 25 microliter 
plasma samples injected into the analyzer--with glucose oxi-
dase. Sample determinations were carried out in duplicate. 
Blood samples were collected in 250 ~1. heparinized micro-
centrifuge tubes (Beckman Co., U.S.A.). They were refrigerat-
ed approximately 24 hours before analysis. Immediately prior 
to analysis, samples were centrifuged in a Beckman microcen-
trifuge for five minutes, then placed on ice. Plasma glucose 
values, expressed iri mg./dl., were obtained directly from the 
glucose analyzer. 
B. Experimental Protocols 
Fasted rats were subjected to one of the following treat-
rnents: 
1. 1 ml. dexamethasone acetate ip (100 ~g./ml. in saline) 
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1 ml. saline iv; 
2. 1 ml. dexamethasone acetate ip, 
1 ml. endotoxin (5 mg ./ml. in saline) iv; 
3. 1 ml. saline ip, 
1 ml. endotoxin iv; or 
4. 1 ml. saline ip, 
1 ml. saline iv. 
Injections were given under ether anesthesia. The intraVenous 
route was via the dorsal vein of the penis. Initial blood sam-
ples were obtained, simultaneous with the injections, by tail 
snip. A second blood sample was obtained from ether anesthe-
tized rats by cardiac puncture 180 minutes after treatments. 
In the case of those rats which died prior to 180 minutes, b~ood 
samples were obtained by cardiac puncture at the time of death. 
C. Data Analysis 
Differences between the initial and 180 ·minute glucose 
levels in the individual rats as well as differences between 
180 minute glucose levels of rats receiving different treat-
ments were evaluated by the Student'· s unpaired "t" test with 
p-values less than 0.050 considered significant. P and t val-
ues were calculated by a PDP-12 computer programmed for sta-
·tistical analysis. 
In vivo Evaluation of Glucose Oxidation to co 2 
In order to evaluate glucose oxidation in vivo, fasted 
rats weighing 100+10 grams were administered a dose of 14c-u-
D-glucose (Amersham/Searle, Arlington Heights, Illinois) then 
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placed in individual containers. Their total expired co 2 and 
14co 2 vias trapped in a column containing co 2 trapping fluid. 
The percent of the ~dministered label which was recovered 
served as an index of glucose oxidation by the whole rat. 
A. Treatment of Rats 
In order to evaluate glucose oxidation in vivo, rats 
received a dose of 7 ~Ci of u~iformly labeled 14c-D-glucose 
at time 0 minutes. The labeled glucose was prepared in pyro-
gen-free saline at a concentration of 10 ~Ci/ml.; each rat was 
injected with 0.70 ml. intraperitoneally. 
The dose of C-14-glucose administered to each rat was 
14 determined by counting 10 ~1. aliquots of the C-glucose so-
lutioh to be injected in ten ml. of PCS (Amersham/Searle) in 
an. Isocap 300 Liquid Scintillation System (Amersham/Searle). 
This count was corrected for counting efficiency by the Sam-
ple Channels Ratio method. The calculated disintegration rate 
multiplied by 70 to give the corrected 14c d6se in a 0.70 was 
ml. injection. 
In addition to the administration of labeled glucose, 
rats received one of the following sets of injections: 
l. 0.5 ml. of endotoxin (1.5 mg./ml. in pyrogen-free 
saline) iv; 
2. 0.5 ml. of salin~ iv; 
3. 0.5 ml. saline iv and 0.75 ml. saline ip three hours 
prior to glucose ip; 
4. 0.5 ml. endotoxin iv and 0.75 rnl. saline ip at three 
hours prior to glucose ip; or 
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5. 0.5 ml. endotoxin iv and o.75 ml. dexamethasone 
acetate (100 ~g./ml. in pyrogen-free saline) three 
hours prior to glucose ip. 
B. co 2 Trapping Apparatus 
Immediately after receiving the labeled glucose injec-
tion and other treatments, rats were placed in individual 
bottles, each containing about 750 ml. of wood shavings to 
absorb moisture. The bottles had two outlets: one -for draw-
ing and mixing room air within the bottle for the rat to 
breathe, and one connected by tubing to a gas inflow attach-
ment of a co 2 bubble trap (Figure 1) from MRA Corp., Boston, 
Massachusetts. The gas inflow tube was submersed in 52 ml. 
of a co2 trapping fluid (33) ( 2 volumes 2-methoxyehhanol: 
1 volume ethanolamine). A gas outflow side arm of the co2 
trap was connected to a vacuum source. Flow through each co2 
trap was regulated by a needle valve connected in series with 
the trap and the vacuum source. Also connected in series be-
tween the trap and the valve was a flowmeter (Fisher Scien-
tific Co., Chicago, Illinois); flow was adjusted to 500 ml., 
per minute as determined by the flow meters. Two stopcocks 
set in the main body of the co2 trap could be adjusted to 
permit vacuum-induced mixing of co2 with the trapping fluid, 
or sampling of the trapping fluid. 
C. Sample Processing 
Duplicate 1 ml. samples of the trapping fluid were taken 
immediately before and at specified times after placing the 
rats in their bottles. A 1 ml. Oxford Sampler (Scientific 
FIGURE 1 29 
IN VIVO 14co TRAPPING APPARATUS 
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Products, Oxford, California) with disposable pipette tips 
was used. Samples \vere taken at 15 minute intervals for the 
first hour of co 2 collection, and subsequently at 30.minute 
intervals for the remaining three hours of the experiment. 
Ten ml. of liquid scintillation counting fluor was mixed in 
a scintillation vial with each 1 ml. ali~uot of trapping fluid. 
The fluor composition was 70% ,(by volume) toluene (AR grade, 
Mallinckrodt); 20% 2-methoxyethanol (Aldrich Chemical Company, 
Milwaukee, Wisconsin); and 10% ethanolamine (Aldrich Chemical 
Company). To each liter of this solution, 7.0 grams of PPO 
(2,5-diphenyloxazole, Scintillation Grade, Amersham/Searle) 
' 
and 0.15 gram POPOP (p-bis-2-(5-phenyloxazolyl)benzene, Scin-
tillation Grade, Amersham/Searle) were added (6). Samples were 
counted.in the liquid scintillation counter for 20 minutes or 
to a maximal count of 800,000. 
Counting efficiency was determined by the method of in-
ternal standards using calibrated toluene-C-14 (Amersham/ 
Searle). 50 ~1. aliquots of the labeled toluene were added 
to samples which had been counted previously as well as into 
vials containing only fluor. These samples were counted and 
an efficiency of 76.47% was calculated and used for data analy-
sis. 
D. Data Analvsis 
Data are expressed as the percent of the injected 14-C 
dose recovered cumulatively at each time point. Count rates 
obtained from samples taken prior to placing the rats in their 
bottles served as background count rates. The background count 
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rate was then subtracted from the cumulative count rate at 
each time point. Data calculations were performed by means 
of a computer program (6} which could accumulate the mean count 
rate of the duplicate 1-ml. samples for each time point, simul-
taneously correcting for background, counting efficiency, re-
moval of the 14c-label in previous samples, and the volume of 
trapping fluid remaining at the time a particular set of sam-
ples was taken. The cumulative disintegrations per minute 
(DPM) data was then converted to percent recovery of the 14c-
label by dividing the DPM recovered at each time point by the 
initial DPM in the administered dose of 14c-glucose. 
14 Means and standard errors of the C-recovery data for 
each experimental group were obtained with the use of a corn-
puter program designed to calculate these statistics. A corn-
puter program also evaluated statistical differences by the 
unpaired Student's "t" test. 
In Vitro EValuation of' Glucos·e· Oxidation to co2 
A. Tissue Preparations 
Fasted rats (100+10 grams) were decapitated and a va-
riety of tis.sues removed for an in vitro evaluation of glu-
cose oxidation. Blood from the carcass was collected in a 
20-rnl. beaker containing 5000 units of heparin (Sigma). A 
1 rnl. aliquot of the blood \<las pipetted into a metabolic 
flask (see below). The right hemidiaphragrn and left epididy-
mal fat pad were removed in their entirety and placed in in-
dividual metabolic flasks. A portion of the stomach was re-
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moved and everted, serving as a sample of gastric mucosa. Por-
tions of the liver, spleen, ventricle, kidney, lungs, and brain 
were removed and slices approximately 500 micrometers thick 
were prepared using the Stadie-Riggs method (64). All tissue 
specimens were rinsed in iced physiological saline, blotted, 
and weighed before being placed in metabo~ic flasks. The num-
ber of slices of each tissue was varied such that a total sam-. 
ple of 200-500 mg. was generally maintained. Metabolic flasks 
containing incubation medium (see below) were kept on ice 
throughout the period of tissue sample preparation. Blood and 
samples to be sliced were also kept on ice. 
B. Rat Treatments 
For the series of experiments in which glucose oxidation 
by ten different tissues was evaluated, t'l.vo groups of rats 
were used. One group was untreated, serving as controls. The 
second group received 0.5 ml. endotoxin (1.5 mg./ml. in sa-
line) iv three hours prior to sacrifice. 
. f 14 0 . 1 A ser1es o C 2 recovery exper1ments were a so car-
ried out using only epididymal fat pads. The specific treat-
ment of each group of rats or fat pads is detailed in the Re-
sults section. Bovine crystalline insulin (Sigma) and ATP•Mg+ 2 
.(Sigma) were used for a series of experiments at the concen-
trations specified. Each experimental group had its own cor-
responding control group. When fat pads were removed from 
treated rats, control fat pads were obtained from rats from 
the identical shipment as the experimental animals. Ln fat 
pad experiments.in which a constituent of the incubation 
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medium was being manipulated, one epididymal fat pad served 
as an experimental fat pad and the second epididymal fat pad 
served as a control. In the latter instance, use of the right 
and left fat pad as experimental or control was varied in 
order to minimize possible intrinsic differences in right ver-
sus left fat pad weight or metabolism. 
c. 14co 2 in vitro Trapping:Apparatus 
The in vitro method of Saba and DiLuzio (53) was used 
14 for the collection of expired tissue co 2 and co 2 . Tissues 
were placed in 50 ml. metabolic flasks (Kontes Glass Co., 
Vineland, New Jersey) with Teflon adapters screwed onto the 
side arms. Scintillation vials (Wheaton .Scientific, Hillville, 
New Jersey) with a cap diameter of 24 mm. were fitted onto the 
side arm. A 4.0 by 0.75 inch strip -of \·Jhatman No. 52 filter 
paper soaked in 0.3 ml. of hyamine hydroxide (1.0 molar in 
methanol, Amersham/Searle) was placed in each scintillation 
vial. Vials were attached to the metabolic flasks to trap the 
expired co 2 . 
Five ml. of incubation medium was added to each flask 
shortly before the tissue specimen was added. ·The incubation 
medium was a modified Krebs-Ringer-Phosphate solution (67) 
(101.5 ml. 0.9% NaCl: 4 ml. l.l5%KC1: 1.5 ml. 1.22%CaC1 2 : 
l ml. 3.82% Hgso 4 .7 H20: 20 ml. 0.1 H phosphate buffer, pli 
7.4). It was maintained at a pJ of 7.38-7.39. One hundred 
. 14 ·; mg. of D-glucose and 50 ~1. of U- C-glucose (1 OCl ~1., Amer~ 
sham/Searle) were added to the modified I\rebs-Ringer-Phosphate 
to a final volume of 100 ml. The resultant medium had a 
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glucose concentration of 1 mg./ml. and an activity of 0.5 ~ci/ 
ml. After tissues were placed in the flask, and while still 
on ice, each flask was gassed for 60 seconds with 100% o 2 • 
The flasks were placed in a Dubnoff metabolic shaker bath main-
tained at 37° C and shaken at a rate of 60 cycles per minute. 
The efficiency of the 14co2 trapping process was tested 
by .adding a 17 JJl. aliquot of a calibrated 14c-NaHC0 3 solution 
(Amersham/Searle) to 100 ml. of saline. 1 ml. of this solu-
tion was combined with 4 ml. of saline in a metabolic flask. 
One ml. of 62.5% citric acid was injected into the flask. 
retovery was evaluated at 30, 60, 90, and 120 minutes in sepa-
rate flasks. 
14 . . 
About 90% of the C-label was recovered after 
30 minutes; percent recovery was fairly constant for 60, 90, 
and 120 minutes. It was concluded that essentially all 14co 2 
being evolved would be · recovered. 
D. 14co 2 Sample Processing 
14 In experiments designed to evaluate co2 recovery in 
ten different tissues, incubation was carried out for 120 min-
utes. At this time the scintillation vials on the flasks were 
replaced and 1 ml. of 62.5% citric acid was injected into each. 
Incubation was continued for 15 minutes, in order to recover 
14
co 2 trapped within the medium. In those experiments in which 
only epididymal fat pad oxidation was evaluated, scintillation 
vials were replaced at 30, 60, 90, and 120 minutes after in-
itiation of the incubation period. Again at 120 minutes, 1 
ml. of citric acid was injected and incubation was continued 
for 15 minutes more. 15 ml. of liquid scintillation fluor 
(1 liter toluene: 4.0 gm. PPO: 
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0.1 gm. POPOP) was added to 
each vial. The vials were counted in a liquid scintillation 
counter for 10 minutes, after a dark-adaptation period of 
about 30 minutes. 
E. Data Calculation and Analvsis 
Data was expressed as total DPM of· 14co 2 recovered per 
gram wet weight of the appropiiate tissue, or per one ml. of 
blood. Due to the occasional vaporization of water in the 
scintillation vial during incubation, which . caused a decrease 
in the counting efficiency, conversion of CPM to DPM was cal-
culated individually for each sample. A computer programwas 
used which constructed a sample channels ratio vs. efficiency 
curve based upon a C-14 standard quench set (Amersham/Searle) 
count rate. The problem of water vaporization in the scin-
tillation vials was very minor. Most samples counted with 
an efficiency of approximately 85%. 
The DPM from the 120 minute incubation and from the 
14co 2 collection period were added and this total divided by 
the tissue weight. Thus data for the "tissue survey" exper-
iments is represented as total DPM per 120 minutes of incuba-
tion per gram wet weight of the tissue (or per 1 ml. blood). 
For experiments in which only epididymal fat pads were used, 
recovered DPM were totalled at each time point (i.e., 30, 60, 
90, and 120 minutes). Data is expressed as cumulative DPM per 
gram wet weight, at each time point. Means, standard errors, 
and statistical differences b~tween groups were evaluated with 
the use of computer programs described above. 
RESULTS 
Protection by Dexamethasone· against Endotoxin Shock Lethality 
Experiments were carried out in order to evaluate the 
ability of dexamethasone to significantly blunt endotoxic shock 
lethality. Experimental results and a statistical analysis 
I 
are pr~sented in Table l, and are depicted in Figure 2.As de-
picted, administration of 100 ~gm. of dexamethasone acetate 
simultaneously with the administration of endotoxin resulted 
in a significant depression of the percent lethality. In 
groups administered 4 (groups 5 vs. 6) or 8 (groups 7 vs. 8) 
mg. of endotoxin, lethality was significantly reduced from 
70% to 5%, and from 80% to 10%, respectively. Groups adminis-
tered l (groups l vs. 2) or 2 (groups 3 vs. 4) mg. of endotox-
in demonstrated a reduction in lethality from 15% to 0%, and 
from 30% to 15%, respectively; reduction of lethality in these 
groups was not . significant as reflected in p-values in th~ 
range of 5-50%. 
Dexamethasone Protection A9"ainst Endotoxic Hypo9"lycemia 
Administration of 5 mg. of endotoxin to fasted rats re-
sulted in the development of a severe hypoglycemia (Table 2). 
By 180 minutes post-endotoxin, plasma glucose levels dropped 
from 86.8 to 24.0 mg./dl. Concomitant administration of 100 
~g. of dexamethasone acetate not only served to prevent the 
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TABLE 1 
PROTECTION BY DEXA~illTHASONE AGAINST ENDOTOXIN SHOCK LETHALITYa 
Group Number 1 2 3 4 5 6 7 
Endotoxin dose b 1 1 2 2 4 4 8 
(mg./rat) 
DXMd Treatment Salinec Saline DXM Saline DXM Saline 
Number tested 20 20 20 20 20 20 20 
Rat weight 317.te 318.6 320.3 321.2 320.3 323.3 320.4 
(grams) 5.9 3.8 3.5 3.1 2.4 3.5 2.3 
% Lethality 15% 0% 30% 15% 70% 5% 80% 
Statistical Analysis of Lethality Data 
Control Group Experimental Group Chi-square Value P-value 
1 2 1.4414 5-50% 
3 4 0.5735 5-50% 
5 6 15.3600 0. 1% 
7 8 17.0707 0.1% 
8 
8 
DXH 
20 
323.7 
3.4 
10% 
w 
-...J 
Footnotes to Table 1 
a. Lethality was defined as death occurring within 48 
hours after endotoxin administration. 
b. Endotoxin ~as administered intravenously and was pre-
pared in concentrations of 1, 2, 4, or 8 mg./ml. in 
pyrogen-free saline, each rat receiving 1 ml. 
38 
c. Saline treatment consisted of intraperitoneal injection 
of 1 ml. pyrogen-free saline. 
d. Dexamethasone treatment consisted of intraperitoneal 
injection of 1 ml. dexamethasone (100 ~g./ml. prepared 
in pyrogen-free salinel. 
e. Value represents mean. 
f. Value represents standard error. 
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TABLE 2 
PROTECTlON BY DEXAMETHASONE AGAINST ENDOTOXIC HYPOGLYCEMIA 
Group 
Number in group 
Rat weight (grams) 
Treatment 
A 
10 
a 280.0b 
6.3 
100 J.lg. DXM ip 
1 ml saline iv 
Plasma Glucose (mg./dl.) 
at 0 minutes: 82.2 
2.9 
101.4 
2.2 
at 180 minutes: 
a. 
b. 
0 minutes 
A--B 
B--e 
0. 6dc 
0. 6 . 
0.4 
0.7 
Value represents mean. 
B 
10 
282.6 
3.7 
100 J.lg. DXM ip 
5 mg. LPS iv 
84.8 
3.3 
129.3 
3.4 
Statistical Analysis 
180 minutes 
A--B 
B--e 
A--D 
Footnotes 
6.9 
o.o 
11.0 
o.o 
3.9 
o.o 
c D 
9 10 
273.0 268.3 
2.6 4.0 
1 ml. .saline ip 1 ml. saline ip 
5 mg. LPS iv 1 ml. saline iv 
86.8 80.5 
3. 5 . 2.3 
24.0 90.2 
9. 0 . 1.8 
0 -minutes--180 minutes 
A 5.2 
o.o 
B 9.4 
o.o 
c 6.5 
o.o 
D 3. 3 
o.o 
c. 
d. 
Value represents standard error. 
Value represents t-value. 
Value represents p-value; value less than 0.050 considered significant. 
,J::>. 
0 
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development of hypoglycemia but elevated plasma glucose levels 
from 84.8 to 129 mg./dl. by 180 minutes post-treatment. Treat-
ment of rats with 100 ~g. of dexamethasone acetate alone resul-
ted in a significant increase in plasma glucose levels from 
82.2 to 101.4 mg./dl. within 180 minutes; however this incre-
ment was lesser than that observed in dexamethasone-treated 
endotoxic rats. Plasma glucos~ levels in saline-treated rats 
exhibited a small but significant increase, from 80.5 to 90.2 
mg./dl., by 180 minutes post-treatment. 
In vivo 14co2 Recovery follo\AJin<J 
14
c-D-Glucose Administration 
Glucose oxidation in the endotoxic rat, and its modula-
tion by dexamethasone acetate, was evaluated by recovery of 
14
co2 following intraperitoneal administration of a tracer dose 
14 
of uniformly labeled C-glucose. Experimental treatments for 
the five experimental groups are outlined in Table 3. Data 
for the five groups is presented in Table 4, and depicted in 
Figures 3 and 4, and is expressed as percent of the initial 
dose of 14c recovered at each time point. 
Statistical analysis (Table 5) of groups 1 and 2 reveals 
a significant increase in percent 14co2 recovered--hence, sig-
nificant enhancement of glucose oxidation--by rats treated with 
0.75 mg. endotoxin by 180 minutes post-treatment. When co 2 
collection was started 180 minutes following administration of 
endotoxin or saline (groups 3 and 4), significant glucose hy-
percatabolism by the endotoxic rats ·was demonstrated by 30 min-
t f d . . . f 14 1 u es a ter a m1n1strat1on o C-g ucose. The ability of dexa-
methasone acetate to blunt the hypercatabolism was demonstrated 
a 
b 
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TABLE 3 
EXPERIMENTAL TREATMENI~ OF GROUPS OF RATS FOR 14co2 COLLECTION AFTER C-D-GLUCOSE ADMINISTRATION 
Group Number 
1 
2 
3 
4 
5 
Experimental Treatment 
0.5 ml 14saline iv at t. 0 min.; 
.7 ml. C-glucose ip at t. 0 min. 
0.5 ml. 1~PSa iv at t. 0 min.; 
.7 ml. C-glucose ip at t. 0 min • 
. 75 ml. salin~ ip at t. -180 min.; 
.5 ml. ~~line iv at t. -180 min.; 
.7 ml. C-glucose ip at t. 0 min • 
. 75 ml. saline ip at t. -180 min.; 
.5 ml. ~~S iv at t. -180 min.; 
.7 ml. C-glucose ip at t. 0 min . 
. 75 ml. dexamethasonebip at t. -180 min; 
.5 ml. ~~s iv at t. -180 min.; 
.7 ml. C-glucose ip at t. 0 min. 
LPS is S. enteriditis lipopolysaccharide, 1.5 mg./ml. 
Dexamethasone is prepared at a concentration of 100 ~g./ml. 
TABLE 4 14
co RECOVERY AFTER IP 14c-D-GLUCOSE 2 
Group Number l 2 3 4 
Number in. group 13 15 8 12 
Weight (grams) l0ll)2<;l 102.4 116.1 114.8 
5.0 4.8 4.2 2.6 
% Dose recovered 
after ip glucose 
at 15 min. 1.12 0.83 l. 30 . l. 29 . 
0.10 0.09 0.11 0.09 
30 min. 2.84 2.66 3.14 4.17 
0.16 0.19 0.19 0.29 
45 min. 5.52 5.39 5.49 7.68 
0.25 0.28 0.33 0.39 
60 min. 8.51 8.82 8.15 11.50 
0.40 0.37 0.37 0.62 
90 min. 14.93 16.20 13.69 18.36 
0.61 0. 39 0.59 0.82 
120 min. 20.59 21.94 18.03 22.94 
0.71 0.41 0.69 0.70 
150 min. 25.16 27.13 21.42 26.46 
0.88 0.41 0.77 l. 20 
180 min. 28.16 30.81 23.84 28.88 
0.99 0.43 0. 86 l. 27 
210 min. 30.55 33.39 25.75 30.89 
l. 03 0.44 0.88 l. 35 
240 min. 32.39 35.18 26.94 32.45 
l.ll 0.44 0.91 0.47 
a 
represents bValue mean. 
Value represents standard error. 
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5 
9 
120.0 
2.0 
l. 26 
0.09 
3.53 
0.27 
6.41 
0.44 
9.59 
0.57 
15.09 
0.70 
19.08 
0.70 
21.85 
0.75 
23.99 
0.83 
25.34 
0.68 
26.69 
0.92 
TABLE 5 
SELECTED STATISTICAL COMPARISONS 
OF IN VIVO 14co 2 RECOVERY DATA 
Groups Compared 1--2 3--4 4--5 
Degrees of Freedom 26 18 19 
Rat weight 0.17a 0.26 1. 59 
0.87b 0.79 0.13 
% Recovery after 
C-14- Glucose at: 
15 min. 2.08 0.12 0.18 
0.05 0.91 0.85 
30 min. 0.75 2. 9,5 1. 62 
0.46 0.01* 0.12 
45 min. 0.33 4.32 2.15 
0.74 0.00* 0.03* 
60 min. 0.57 4.67 2.27 
0.57 0.00* 0.01* 
90 min. 1. 74 4.64 3.02 
0.09 0.00* 0.01* 
120 min. 1. 65 3.87 3.03 
0.11 0.00* 0.01* 
150 min. 2.03 3.54 3.26 
0.05 0.00* 0.00* 
180 min. 2.46 3.27 3.22 
0.02* 0.00* 0.00* 
210 min. 2.54 3.19 3.67 
0.02* 0.00* 0.00* 
240 min. 2.35 3.18 3.32 
0.02* 0.00'* 0.00* 
a t-value b p-va1ue 
* significant difference, with p-value less than 
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3--5 
15 
0.84 
0.42 
0.29 
0.78 
1.18 
0.25 
1. 67 
0.05 
2.11 
0.15 
l. 52 
0.11 
l. 07 
0.30 
0.40 
0.70 
0.12 
0.90 
0.36 
0.72 
0.20 
0.84 
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by group 5, administered dexamethasone acetate simultaneous-
ly with endotoxin. By 45 minutes after administration of 1 4c-
glucose, 14co2 recovery in dexamethasone-treated endotoxic 
rats was reduced to control levels. 
In vitro 14co Recovery· from Rat Tissues 2 
In order to identify the specific tissue loci of endo-
toxic glucose hypercatabolism, 14co was recovered in vitro 2 
from ten tissues removed from either control or endotoxic 
rats. Results and a statistical analysis are presented in 
T bl 6 C 1 f 14 0 . 1 d' h 1 d a e . omp ete recovery o C 2--1nc u 1ng t at re ease 
to the incubation medium--over a 120 minute incubation period 
was quantitated. 
As depicted in Table 6, liver slices, spleen slices, 
hemidiaphragms and epididymal fat pads removed from endotoxic 
rats oxidized significantly more glucose than the respective 
tissues removed from untreated rats. Glucose oxidation by 
blood and gastric mucosa, and by ventricle, kidney~ lung, and 
brain slices removed from endotoxic rats was not significant-
ly enhanced. 
In vitro 14co2 Collectioh from Epididymal Fat Pads 
Characterization of endotoxic glucose hypercatabolism 
was carried out in a series of experiments using epididymal 
fat pads. The 48 experimental groups, their treatments, the 
data and statistical analyses are presented in Tables 7 through 
11, and results are depicted in Figures 5 through 9. 
The ability of endotoxin in vivo to significantly en-
hance glucose oxidation by epididymal fat pads was demonstrated 
Tissue N 
Blood 9 
8 
Liver 9 
9 
Hemidiaphragrn 8 
9 
Epididymal 8 
Fat Pad 8 
Spleen 9 
9 
TABLE 6 
IN VITRO 14co 2 RECOVERY FROM RAT TISSUES 
Tissue ~veight Treatment 14 CO Recovery 
(mg.) (DPMJgm.wet· wt.) 
1 ml. -- 12346+1083'b 
-a 
15988+"2011 1 ml. LPs-· 
344.1+44.0 -- 82441+13970 
357.9+"27.4 LPS 171180+9496 
-
117.8+8.3 -- 278080+21172 
115.8+"6.9 LPS 462270+"63510 
243.3+12.6 -- 76229+6528 
284.7+"27.4 LPS 98171+"6155 
-
232.6+26.8 -- 569470+54615 
255.1+16.5 LPS 758410+50599 
P-values 
0.13 
o.oo 
0.01 
0.03 
0.02 
.!=>-
co 
TABLE 6 CONT. 
Tissue N Tissue Weight Treatment 
~mg.) 
Ventricle 9 244.1+22.5 --
9 241.4+25.6 LPS 
Kidney 9 213.2+17.3 --
9 245.0+"14.3 LPS 
Lung 9 259.2+26.7 --
9 258.0+"18.8 LPS 
Brain 9 174~1+10.8 --
9 200.1+"25.8 LPS 
Gastric 9 756.3+37.7 --
mucosa 9 809.3+"33.7 LPS 
~0.5 ml. LPS (1.5 mg./ml.) administered at t. -3 hours. 
Values represent mean+standard error. 
14 CO Recovery 
(DPHJgm. wet wt.) 
299750+44175 
306280+"43723 
974270+92705 
944430+"65995 
-
241240+27045 
312200+"33012 
-
1698300+192790 
1847400+184640 
101770tl.6453 
119860+"15528 
P-values 
0.92 
0.80 
0.12 
0.58 
0.44 
.j:>. 
\.0 
by group 2 at all time points studied. Such data would ap-
pear to correspond to in vivo 14co2 collection data presen-
ted previously in which significant glucose hypercatabolism 
was demonstrated by 30 minutes after the administration of 
14 C-glucose, when endotoxin had been administered 180 min-
14 
utes prior to the C-glucose. 
That endotoxic glucose hypercatabolism could not be 
50 
caused by direct interactions between endotoxin and the epi-
didymal adipose was shown by the addition of endotoxin in 
concentrations of 50, 100, or 200 ~g./ml. to the incubation 
medium. 14co recovery over a 120-minute incubation period 2 
from fat pads placed in a medium containing endotoxin was not 
significantly enhanced with any concentration of endotoxin, 
as compared to recovery from the matched fat pads (groups 7 
vs. 8; 9 vs. 10; and ll vs. 12). 
Blunting of endotoxic glucose hypercatabolism by si-
rriultaneous administration of dexamethasone acetate with the 
endotoxin could be demonstrated in vitro by the epididymal 
fat pad (group 3) . Significant depression of glucose hyper-
catabolism in fat pads removed from endotoxic dexamethasone-
treated rats was demonstrable by 60 minutes after the onset 
of incubation. Such an inhibition of glucose oxidation by the 
1n vivo administration of dexamethasone could not be demon-
strated with fat pads removed from non-endotoxic dexametha~ 
sane-treated rats (group 5); no significant difference could 
be demonstrated at any time point when compared to a group of 
fat pads from untreated rats (groups 5 vs. 6). 
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TABLE 7 
IN VIVO INFLUENCE OF ENDOTOXIN AND DEXAMETHASONE 
--oN EPIDIDYMAL FAT PAD GLUCOSE OXIDATION 
Group Number 
1 
2 
3 
4 
5 
6 
Treatment 
0.5 ml. LPS (1.5 mg./ml.) iv at t. -3 hr 
0.5 ml. saline iv at t. -3 hr. 
0.5 ml. LPS iv and 0.5 ml. dexamethasone 
acetate (150 ~g./ml.) ip at t. -3 hr. 
0.5 ml. LPS iv and 0.5 ml. saline ip at 
t. -3 hr. 
0.5 ml. dexamethasone acetate ip at t. 
-3 hr. 
0.5 ml. saline ip at t. -3 hr. 
TABLE 7 CONT. 
Group Nurrber 
14co2 Recovery from Epididymal Fat Pads l 2 3 4 
Rat %7eight a 105.1 105.7 106.9 l07.5b 
{grams) 5.1 6.7 1.9 2.1 
Fat Pad Weight 307.5 287.7 305.6 301.9 
(mg.) 20.2 23.7 16.8 15.4 
Number in Group 12 14 14 16 
Cumulative DPM recovered 
per gram wet weight at: 
30 minutes 9722 5236 8942 11069 
1009 334 976 1177 
60 minutes 32781 18485 27436 35941 
2514 1223 2957 3304 
90 minutes 58218 34902 48902 63995 
3468 2118 4809 5043 
120 minutes 83983 52409 70247 92 804 
4415 2884 6925 6448 
co 2 collection 6836 5412 6217 7857 459 2 89 327 336 
a brepresents mean value 
represents standard error ; 
data presented in Tables 8 through ll is arranged in similar fashion 
5 
122.2 
2.3 
316.8 
8.7 
10 
4695 
589 
14531 
1555 
27036 
2477 
40520 
3259 
4500 
144 
6 
121.8 
1.3 
341.6 
13.4 
10 
4676 
287 
14568 
843 
28558 
1222 
43508 
1642 
4840 
185 
Ul 
I\.) 
TABLE 7 CONT. 
Statistical Analysis 
Groups Compared 1--2 3--4 5--6 
Rat weight 
. a 
0.28b Q.41 0.15 
0.78 0~69 0.88 
Fat pad weight 0.64 0.16 1. 55 
0.53 0.87 0.14 
Degrees of Freedom 24 28 18 
Cumulative DPM recovered 
per gram wet weight at: 
30 minutes 4.22 1. 39 0.03 
0.00 0.17 0.98 
60 minutes 5.09 1. 92 0.02 
0.00 0.06 0.98 
90 minutes 5.74 2.16 0.55 
0.00 0.04 0.59 
120 minutes 5.99 2.38 0.82 
o.oo 0.02 0.42 
co2 collection 2.62 3.50 1. 45 0.01 o.oo 0.16 
a brepresents t~value 
represents p-value; value less than 0.050 considered 
significant 
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TABLE 8 
IN VITRO INFLUENCE OF ENDOTOXIN 
ON EPIDIDYMAL FAT PAD GLUCOSE OXIDATION 
Group Number 
7 
8 
9 
10 
11 
12 
Treatment 
LPS ( 50 ~g./m1.) added to incubation 
medium 
LPS (100 ~g./m1.) added to incubation 
medium 
LPS (200 ~g./m1.) added to incubation 
medium 
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TABLE 8 CONT. 
Group Number 
14co 2 Recovery from Epididyma~ Fat Pads 7 8 9 10 
Rat Weight 114.8 114.8 118.8 118.8 
(grams) 1.0 1.0 4.3 4.3 
Fat Pad Weight 321.6 320.8 358.8 360.8 
(mg.) 35.2 34.7 38.1 38.0 
Number in Group 5 5 5 5 
Cumulative DPM recovered 
per gram wet weight at: 
30 minutes 4843 5290 4547 4608 
677 1223 278 331 
60 IT1inutes 16406 18426 16348 16267 
2344 4449 1286 1171 
90 minutes 31111 34273 31008 31000 
4189 7051 2200 
,.,, 
1958 
120 minutes 47417 51468 48277 48165 
5888 9010 3382 2884 
co 2 collection 4851 5061 5942 5482 554 463 526 409 
11 
123.0 
4.2 
318.4 
26.1 
5 
4583 
360 
15918 
1340 
30754 
2124 
47892 
3288 
5203 
209 
12 
123.0 
4.2 
318.0 
. 25.4 
5 
4761 
287 
16339 
1283 
30915 
2173 
47428 
3415 
5042 
328 
U1 
U1 
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TABLE 8 CONT. 
Statistical Analysis 
Groups Compared 7--8 9--10 11--12 
Rat \veigh t 
Fat Pad Weight 0.02 0.68 0.01 
0.99 0.51 0.99 
Degrees of Freedom 8 8 8 
Cumulative DPM recovered 
per gram wet weight at: 
30 minutes 0.32 0.14 0.36 
0.76 0.89 0.72 
60 minutes 0.40 0.05 0.23 
0.70 0.96 0.83 
90 minutes 0.38 0.00 0.05 
0.71 0.99 0.96 
120 minutes 0.38 0.02 0.10 
0.72 0.98 0.92 
co2 collection 0.29 0.69 0.41 0.78 0.51 0.69 
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TABLE 9 
IN VITRO INFLUENCE OF DEXAMETHASONE 
ON~PIDIDYMAL FAT PAD GLUCOSE OXIDATION 
Group Number 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
Treatment 
dexamethasone acetate (50 ~g./m1.) 
added to incubation medium 
dexamethasone acetate (100 ~g./ml.) 
added to incubation medium 
dexamethasone acetate (200 ~g./m1.) 
added to incubation medium 
0.5 ml. LPS (1.5 mg./m1.) iv at t. -3 hr. 
dexamethasone acetate (50 ~g./m1.) 
added to medium 
0.5 m1. LPS iv at t. -3 hr. 
0.5 m1. LPS iv at t. -3 hr. 
dexamethasone acetate (100 ~g./ml.) 
added to incubation medium 
0.5 m1. LPS iv at t. -3 hr. 
0.5 m1. LPS iv at t. -3 hr. 
dexamethasone acetate (200 ~g./m1.) 
added to incubation medium 
0.5 m1. LPS iv at t. -3 hr. 
TABLE 9 CONT. 
Group Number 
14co 2 Recovery from Epididym~l Fat Pads 13 14 15 16 
Rat Weight 110.1 110.1 113.4 113.4 
(grams) 4.0 4.0 2.6 2.6 
Fat Pad Weight 262.7 272.2 308.9 306.2 
(mg. ) 25.5 23.5 19.3 17.6 
Number in Group 9 9 9 9 
Cumulative DPM recovered 
per gram wet weight at: 
30 minutes 5595 5530 4455 4573 
487 653 435 521 
60 :minutes 20539 20115 15479 17071 
1924 1998 1157 1343 
90 minutes 37565 37499 29740 32337 
3034 3173 1868 2483 
120 minutes 54743 54788 43507 46321 
4348 4618 3010 4029 
150 minutes 72620 72718 59272 62427 
5477 5866 3855 5107 
180 minutes 78321 92979 75512 79 386 
9160 7033 4386 5943 
co2 collection 4621 5081 4593 5236 539 478 326 594 
17 
109 . . 6 
3.3 
295.6 
20.9 
9 
4373 
482 
14576 
1534 
27364 
2361 
39806 
3410 
54019 
420 7 
69051 
4720 
4068 
240 
18 
109.6 
3.3 
293.1 
23.3 
9 
4494 
610 
15812 
1743 
29740 
2690 
44007 
3858 
58548 
5337 
76132 
5107 
4688 
384 
t.n 
00 
TABLE 9 CONT. 
Group Number 
14co 2 R~covery from Epididymal Fat Pads 19 20 21 22 
Rat Weight 110.8 110.8 109.2 109.2 
(grams) 4.2 4.2 2.1 2.1 
Fat Pad Weight 330.7 331.2 317.6 318.0 
(mg.) 20.9 23.6 14.7 16.4 
Number in Group 8 8 9 9 
Cumulative DPM recovered 
per gram wet weight at: 
30 minutes 12111 14436 10063 13095 
1205 9 82 218 364 
60 minutes 32817 38921 25033 34586 
3294 2814 770 1607 
90 minutes 50781 62781 41375 56979 
5124 4755 1298 2735 
120 minutes 60831 85472 56749 79312 
10378 6138 19 78 3835 
150 minutes 94345 92253 70644 100390 
10279' 15509 2690 5100 
180 minutes 113520 129170 84656 120460 
12182 9066 3480 6279 
co2 collection 5121 6747 3838 5991 543 423 226 329 
23 
115.4 
2.5 
316.2 
20.4 
9 
9020 
887 
23215 
2520 
37681 
3873 
51023 
5234 
64213 
6402 
76677 
7683 
3421 
295 
24 
115.4 
2.5 
315.8 
22.7 
9 
15891 
1372 
43182 
4428 
71325 
6825 
98257 
9297 
123880 
11381 
148430 
13621 
7094 
642 
Ul 
1.0 
TABLE 9 CONT: 
Statistical Analysis 
Groups Compared 13--14 15--16 17--18 
Rat Y.Jeight 
Fat Pad Weight 0.27 0.10 0.08 
0.79 0.92 0.94 
Degrees of Freedom 16 16 16 
Cumulative DPM recovered 
per gram wet weight at: 
30 minutes 0.08 0.17 0.15 
0.94 0.86 0.88 
60 minutes 0.15 0.90 0.53 
0.88 0.38 0.60 
90 minutes 0.01 0.81 0.66 
0.99 0.43 0.52 
120 minutes 0.01 0.56 0.82 
0.99 0.58 0.42 
150 minutes 0.01 0.49 0.67 
0.99 0.63 0.51 
180 minutes l. 27 0.52 l. 02 
0.22 0.61 0.32 
co 2 collection 0.64 0.95 l. 37 0.53 0.36 0.19 
19--20 21--22 
0.01 0.02 
0.99 0.98 
14 16 
1.50 7.13 
0.16 0.00 
l. 41 5.36 
0.18 0.00 
1.72 5.15 
0.11 0.00 
2.04 5.23 
0.06 0.00 
0.11 5.16 
0.91 o.oo 
l. 03 4.99 
0. 32 0.00 
2.36 5.40 
0.04 o.oo 
23--24 
0.01 
0.99 
16 
4.21 
o.oo 
3.92 
0.00 
4.29 
o.oo 
4.43 
0.00 
4.57 
0.00 
4.59 
0.00 
5.20 
0.00 
0'1 
0 
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TABLE 10 
IN VITRO INFLUENCE OF INSULIN 
ON EPIDIDYMAL FAT PAD GLUCOSE OXIDATION 
Group Number Treatment 
25 insulin (2.5 ~U/ml.) added to medium 
26 
27 insulin (5 ~U/ml.) added to medium 
28 
29 insulin (10 ~U/ml.) added to medium 
30 
31 insulin (20 ~U/ml.) added to medium 
. 32 
33 0.5 ml. LPS ( l. 5 mg . /ml. ) iv at t. -3 hr 
insulin ( 2. 5 ~U/ml.) added to medium 
34 0.5 ml. LPS iv at t. -3 hr. 
35 0.5 ml. LPS iv at t. -3 hr. 
insulin (5 ~u/ml.) added to medium 
36 0.5 ml. LPS iv at t. -3 hr. 
37 0.5 ml. LPS iv at t. -3 hr. 
insulin (10 ~U/ml.) added to medium 
38 0.5 rnl. LPS iv at t. -3 hr. 
39 0.5 ml. LPS iv at t. -3 hr. 
insulin (20 ~ U/ml.) added to medium 
40 0.5 ml. LPS iv at t. -3 hr. 
TABLE 10 CONT. 
Group Number 
14co~ Re~overy from Epididymal Fat Pads 
25 26 27 28 29 
Rat 'V-7eight 107.7 107.7 96.1 96.1 103.9 
(grams) 5. 4 ' 5.4 4.2 4.2 2.5 
Fat Pad vleight 299.1 289.6 222.8 221.3 264.0 
(mg.) 33.5 34.0 13.6 13.4 9.4 
Number in Group 9 9 9 9 9 
Cumulative DPM recovered 
per gram wet weight at: 
30 minutes 12635 4982 9 882 5449 21060 
2129 589 1656 555 891 
60 minutes 51661 16012 47448 15390 70447 
8513 1305 7720 1286 7033 
90 minutes 100720 30539 97948 30851 130790 
14183 2457 16983 2616 13712 
120 minutes 139300 48310 159760 48360 194710 
24823 3515 25550 4003 23358 
co2 collection 14142 4413 13437 4124 14586 2088 434 2006 439 1866 
30 31 
103.9 105.4 
2.5 2.9 
265.8 277.6 
12.8 18.4 
9 9 
13883 23831 
892 2415 
29016 80069 
1606 11198 
46093 142720 
2624 19239 
62185 212210 
3481 28398 
4150 17470 
374 3170 
32 
105.4 
2.9 
273.8 
19.1 
9 
12081 
2004 
30441 
2584 
47329 
3375 
63487 
3885 
4253 
32 8 
0'\ 
I\.) 
TABLE 10 CONT. 
14co2 Recovery from Epididymal Fat Pads 
Group Number 33 34 35 36 37 38 
Rat Weight 104.1 104.1 105.0 105.0 116.8 116.8 
(grams) 5.1 5.1 5.5 5.5 1.6 1.6 
Fat Pad Neight 268.0 275.2 270.0 267.3 326.0 337.3 
(mg.) 29.3 33.6 25.3 28.8 18.8 13.2 
Number in Group 8 8 9 9 8 9 
Cumulative DPM recovered 
per gram wet wei~ht at: 
30 minutes 22012 13026 26061 11283 47805 23575 
2285 1241 3726 1608 3503 1983 
60 minutes 87178 39694 91499 36121 167140 5 7579 
10996 6091 14557 4445 14658 5658 
90 minutes 159850 72910 173990 62178 291460 .. 87636 
18175 11010 25112 6736 26518 8401 
120 minutes 233560 101060 253510 89431 430800 117390 
25479 14754 34215 9669 39245 11166 
co 2 collection 15017 6697 17180 6770 35843 80 89 2189 664 3042 682 3369 686 
39 
102.4 
2.9 
249.3 
16.2 
9 
38290 
3324 
126820 
10506 
228360 
21036 
315600 
42633 
24486 
2746 
40 
102.4 
2.9 
246.2 
18.7 
9 
12023 
1131 
32041 
2698 
54479 
4427 
78172 
5540 
5006 
379 
0"1 
w 
TABLE 10 CONT. 
•Statistical Analysis 
Groups Compared 25--26 27--28 29--30 31--32 
Rat ~veight 
Fat Pad Weight 0.20 0.08 0.11 0.14 
0.84 0.94 0.91 0.89 
Degrees of Freedom 16 16 16 16 
Cumulative DPM recovered 
per gram wet weight at: 
30 minutes ·. 3. 46 2.54 5.69 3.74 
o.oo 0.02 0.00 o.oo 
60 minutes 4.14 4.10 5.74 4.32 
0.00 0.00 0.00 o .·oo 
90 minutes 4.88 3.90 6.07 4.88 
0.00 o.oo 0.00 o.oo 
120 minutes 3.63 4.31 5.61 5.19 
0.00 o.oo o.oo o.oo 
co 2 collection 4.56 4.41 5.48 4.15 o.oo o.oo o.oo o.oo 
33--34 35--36 
0.16 0.07 
0.87 0.94 
14 16 
3.84 3.64 
0.00 0.00 
3.78 3.64 
0.00 0.00 
4.09 4.30 
0.00 .. 0. 00 
4.50 4.62 
0.00 0.00 
3.64 3.34 
o.oo 0.00 
37--38 
0.49 
0.63 
15 
6.02 
o.oo 
6.97 
0.00 
7.33 
0.00 
7.68 . 
0.00 
8.07 
o.oo 
39--40 
0.12 
0.90 
16 
7.48 
0.00 
8.74 
o.oo 
8.09 
0.00 
5.52 
0.00 
7.03 
0.00 
0'\ 
""' 
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TABLE 11 
IN VITRO INFLUENCE OF ATP 
ON EPIDIDYMAL FAT PAD GLUCOSE OXIDATION 
Group Number 
41 
42 
43 
44 
45 
46 
47 
48 
Treatment 
ATP (10- 5M) added to incubation medium 
ATP (10- 4M) added to incubation medium 
0.5 m1. -~PS (1. 5 mg. /ml. ) i v at t. -3 hr 
ATP (10 M) added to incubation medium 
0.5 ml. LPS iv at t. -3 hr. 
0.5 ml. -~PS iv at t. -3 hr. 
ATP (10 M) added to incubation medium 
0.5 ml. LPS iv at t. -3 hr. 
TABLE 11 -CONT. 
Group Number 
14co2 Recovery from Epididymal Fat Pads 41 42 43 44 45 
Rat Weight 116.3 116.3 109.9 109.9 107.1 
(grams) 5.4 5.4 5.1 5.1 3.3 
Fat Pad Weight 309.3 299.8 275.2 265.0 277.5 
(mg.) 28.0 25.2 23.0 20.5 16.6 
Number in Group 8 8 8 8 8 
Cumulative DPM recovered 
per gram wet weight at: 
30 minutes 18982 18761 13475 17024 12745 
4127 3807 1173 1575 1428 
60 minutes 38506 37783 29611 35639 43332 
5492 5401 2251 2819 3802 
90 minutes 57266 56788 46103 53074 75850 
6699 6835 3133 3860 5238 
120 minutes 74976 74100 642.66 71666 106940 
7386 8035 4051 4407 7064 
co 2 collection 4799 4729 4713 5136 7677 411 530 235 207 560 
46 47 
107.1 107.6 
3.3 4.7 
284.0 294.0 
21.0 18.4 
8 9 
10967 11081 
976 1170 
38964 27481 
2853 2779 
70089 45051 
"' 5011 4200 
100340 61748 
6377 5584 
8611 4608 
960 463 
48 
107.6 
4.7 
294.7 
20.5 
9 
9608 
1413 
33465 
4068 
61113 
5859 
87889 
7599 
7374 
813 
0'1 
0'1 
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TABLE ll CONT. 
Statistical Analysis 
Groups Compared 41--42 43--44 45--46 47--48 
Rat Weight 
Fat Pad Weight 0.25 0.33 0.24 0.02 
0.80 0.74 0.81 0. 9 8 
Degrees of Freedom 14 14 14 16 
Cumulative DPM recovered 
per gram wet weight at: 
30 minutes 0.04 l. 81 l. 03 0.80 
0.97 0.09 0.32 0.43 
60 minutes 0.09 l. 67 0.92 l. 21 
0. 9 3 0.12 0.37 0.24 
90 minutes 0.05 l. 40 0.79 2.23 
0.96 0.18 0.44 0.04 
120 minutes 0.08 l. 24 0.69 2.77 
0.94 0.24 0.50 0.01 
C0 2 collection 0.10 l. 35 0. 84. 2.96 0.92 0.20 0.41 0.01 
FIGURE 5 
IN VIVO INFLUENCE OF ENDOTOXIN AND DEXAMETHASONE 
ON EPIDIDYMAL FAT PAD GLUCOSE OXIDATION 
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FIGURE 6 
IN VITRO INFLUENCE OF DEXAMETHASONE 
ON EPIDIDYMAL FAT PAD GLUCOSE OXIDATION 
DXM,ugm./ml. 
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FIGURE 7 70 
IN VITRO INFLUENCE OF INSULIN 
ON EPIDIDYHAL FAT PAD GLUCOSE OXIDATION 
INSULIN,uU/ml. 
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FIGURE 8 71 
IN VITRO INFLUENCE OF INSULIN 
ON ENDOTOXIC EPIDIDYt1AL FAT PAD GLUCOSE OXIDATION 
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FIGURE 9 
IN VITRO INFLUENCE OF ATP 
ON ENDOTOXIC EPIDIDYHAL FAT PAD GLUCOSE OXIDATION 
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The effectiveness of dexamethasone in d~pressing endo-
toxic glucose hypercatabolism could be demonstrated by its 
in vitro administration as well. Dexam~thasone acetate was 
added in concentrations of 50, 100, and 200 ~g./ml. to in-
cubation medium in which endotoxic fat pads were placed. Ow--
ing to the possibility of a necessary 'lag time' for the full 
development of dexamethasone's , actions, co2 collection >vas 
carried out for 180 minutes. Results show that addition of 
dexamethasone acetate in the concentrations of 100 and 200 
~g./ml. significantly depressed glucose oxidation by the endo-
toxic fat pads at all time ,points (groups 21 vs. 22, and 23 
vs. 24); at the concentration of 50 ~g./ml. only the 14co 2 
found in solution and released during the final collection 
period was significantly affected. 
Dexamethasone added to the incubation medium in which 
control fat pads were placed was unable to significantly in-
fluence glucose oxidation at any time point over a l80~min-
ute collection period. As indicated by groups 13, 15, and 17, 
dexamethasone acetate in the concentrati1ons of 50, 100, or 
200 ~g./ml. respectively, did not blunt the basal glucose ox-
idation of untreated fat pads. 
Endotoxin-stimulated glucose oxidation could be enhanced 
further by the in vitro administration of insulin. Addition 
of insulin in concentrations of 2. 5, 5, 10, and 20 ~U/ml. to 
the incubation medium in which endotoxic fat pads were placed 
resulted in a further enhancement of the glucose hypercatabo-
lism, significant for all time points and at all concentrations 
74 
used (groups 33 vs. 34; 35 vs. 36; 37 vs. 38; and 39 vs. 40). 
Insulin-stimulated endotoxic glucose oxidation--as reflected 
by 14co 2 recovery~-was greater than insulin-stimulated glucose 
oxidation of fat pads removed from untreated rats (groups 25, 
27, 29, and 31) at all concentrations used. 
Addition of. ATP in concentrations of 10- 5 and 10- 4 M did 
not significantly blunt glucose uptake and utilization by fat 
pads removed from untreated rats at any time point for a 120 
minute incubation period. ATP in the concentration of · 10- 5 M 
also had no influence on glucose oxidation by endotoxic fat 
pads. -4 However, 10 M ATP significantly decreased endotoxic 
glucose oxidation by 90 minutes after the onset of the incu-
bation period. 
DISCUSSION 
Dexamethasone Protection against Endotoxin Lethality 
The extensive use of corticosteroids in the treatment 
of shock, particularly endotoxic or septic shock, has been 
based on a substantial literature documeriting a protective ef-
fect; however, specific mechanisms underlying this protective 
effect remain unclear. Current studies evaluated the ability 
of a potent glucocorticoid--dexamethasone--to alleviate the 
detrimental effects of bacterial endotoxin on carbohydrate 
homeostasis and thereby to impart resistance to the induction 
of lethality. 
In agreement with ~ vast literature which is affirma-
tive for a shock-protective capability of glucocorticoids, 
administration of 100 ~g. of dexamethasone resulted in a sig-
nificant diminution of lethality from 4 or 8 mg. of Salm. 
enteriditis endotoxin (Table 1 and Figure 2). These results 
concur with the findings of Marecki (40), Mills (44), and Berry 
and Smythe ( 3) in mice; with the results of Woodruff et al. 
(69) in rabbits; and with the findings of Fukuda and Hata (23) 
in rats. At the lower doses of 1 and 2 mg. of endotoxin, le-
thality was sufficiently low in untreated rats~-15% and 30% 
respectively--that a significant protective effect of dexa-
methasone was not apparent. The lethality studies cited above, 
75 
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however, have not served to isolate specific mechanisms where-
by glucocorticoids could exert their protection; most studies 
to date which have evaluated specific protective mechanisms 
have been carried out using glucocorticoids in vitro in iso-
lated systems such as cat papillary muscle (37) or lysosomal 
fractions (20). Based on the demonstration of a protective 
effect for dexamethasone, and on the significant role of al-
tered glucose homeostasis in endotoxic shock (29), further in-
vestigations evaluated the specific influence of dexamethasone 
both in vivo and ~n vitro on select aspects of glucose metabo-
lism. 
Dexamethasone Protection 'against Pos.t-endotoxin Hypoglycemia 
The occurrence of a progressive and profound hypoglyce-
mia following administration of endotoxin lipopolysaccharide, 
live or killed gram-negative bacteria, has been documented in 
several species. Results obtained in these studies represent 
yet another confirmation of the phenomenon of endotoxic hypo-
glycemia (Table 2). Rats treated with 5 mg. of endotoxin iv 
exhibited a drop in plasma glucose levels from 87 to 24 mg./dl. 
within 180 minutes. This rapid onset of hypoglycemia, which 
may serve either as a cause or as a contributing parameter of 
endotoxic lethality has been described previously by Berk (1), 
Hinshaw (29), Filkins et al. (21), Halper et al. (31) and others. 
In the studies described here, 7 out of 10 rats died in con-
vulsions with plasma glucose leVels around 5 mg./dl. The three 
rats which survived for 180 minutes had plasma glucose levels 
around 50 mg./dl. These levels concur with plasma glucose 
levels reported by the investigators cited above which were 
obtained a few hours after the administration of endotoxin. 
Both Berry, Smythe and Young ( 4) . and Hal tzman et al. 
77 
(32) reported a significant increase in blood glucose levels 
in endotoxic mice and rats treated with a glucocorticoid. Re-
sults reported here indicata that rats are not only protected 
from hypoglycemia with the administration of dexamethasone, 
but become hyperglycemic. This somewhat exaggerated response 
was not repo-rted by either Berry et al. or Holtzman et al; 
they noted a maintenance of blood glucose levels near con-
trol but did not report a significant hyperglycemia. Schuler, 
Erve, and Schumer (55) evaluated the influence of dexamethasone 
on various metabolite levels in the liver as well as lethal-
ity, and also reported a maintenance of these levels at con-
trol values. The exaggerated glucose response to dexamethasone 
reported here is also reflected in the alterations of glucose 
oxidation by endotoxic epidd.dymal fat pads which were induced 
by dexamethasone, both in vivo and in vitro, and will be dis-
cussed below. 
Administration of dexamethasone to untreated rats re-
sulted in a small but significant increase in plasma glucose 
levels. The increase in plasma glucose is 1n agreement with 
findings cited by de Bodo and Altszuler in their review (14), 
and is consistent with current knowledge of glucocorticoid 
actions--i.e., their positive influence upon gluconeogenic en-
zyme activity, mobilization of gluconeogenic precursors, and 
inhibition of peripheral glucose uptake should result in an 
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increase in plasma glucose leve ls within a few hours . of their 
administration. For the purpose of the present studies, glu-
cocorticoid inhibition of glucose oxidation was the single 
mechanism evaluated. 
Studies pertaining to glucocorticoid protection against 
endotoxic hypoglycemia suggest that this may represent a sig-
nificant mechanism underlying lethality protection. Hinshaw 
I 
has demonstrated the benefits of glucose infusion in the endo-
toxic dog (30); administration of glucocorticoids may have 
similar therapeutic influence over altered carbohydrate homeo-
stasis, since they can maintain plasma glucose levels, and 
since their influence can be exerted within the first few hours 
after an endotoxic insult, during which alterations of carbo-
hydrate metabolism seem to be critical to the eventual outcome 
of the animal. The positive influence of glucocorticoids over 
blood glucose levels would thus seem to be of clinical as well 
as experimental interest. 
Influence of Dexam:ethas·one on in vivo Glucose Oxidation 
Two major mechanisms have been suggested to account for 
the hypoglycemia of endotoxicosis: impaired ability of the 
liver to synthesize glucose, and enhanced glucose uptake and 
utilization by peripheral tissues. Studies presented here e-
valuated the latter mechanism (Table 4 and Figures 3 and 4). 
Glucose oxidation by the whole animal in vivo was significant-
ly enhanced within a few hours following the administration 
of a non-lethal dose of endotoxin. Such a finding is important 
since it highlights the ability of endotoxin to seriously alter 
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carbohydrate metabolism in an animal which appeared normal 
and which would probably exhibit no significant changes in its 
cardiovascular parameters. Although cardiovascular alterations 
in endotoxicosis have served as the center of investigation 
previously, results such as the present findings emphasize the· 
probability that metabolic lesions precede, and therefore un-
derlie the cardiovascular changes which are often considered 
the cause for endotoxic lethality. 
Studies assessing glucose oxidation in the endotoxic or 
septic organism have been. limited, and few reports document 
an in vivo glucose hypercatabolism. The results discussed here 
are in agreement with results of Buchanan and Filkins (8) in 
the rat; with Bierenbaum et al. (5) in the dog; and with Long 
et al. (38) and Gump et al. (26) in septicemic men. These find-
ings suggest that tissue glucose hypercatabolism represents 
an important mechanism contributing to endotoxic hypoglycemia, 
and thus endotoxin can exert its influence on peripheral tis~ 
sue as well as liver metabolism. The questions of whether or 
not endotoxin can directly effect peripheral tissue glucose 
metabolism, as well as which tissues exhibit glucose hypercata-
bolism, are two important issues which deserve consideration 
once in vivo glucose hypercatabolism has been established, and 
---- . 
will be considered below. 
Since dexamethasone protected the endotoxic rat against 
hypoglycemia, it was of interest to evaluate dexamethasone's 
influence over endotoxic glucose oxidation. Studies revealed 
that dexamethasone administration resulted in a lowering of 
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endotoxic glucose oxidation to a level attained by normal 
rats. These studies impld.!cate inhibition of glucose uptake 
and utilization as a significant contributory mechanism under-
lying the hyperglycemic action of the glucocorticoids. Pre-
vious studies have stressed the ability of glucocorticoids to 
support liver carbohydrate metabolism in .the endotoxic animal; 
these results indicate that glucocorticoids attack the devel-
opment of hypoglycemia at both sites which contribute to it, 
i.e., the liver and peripheral tissues. 
Effects of Endotoxin on Gluc·ose Oxidation by Excised Tissues 
Although endotoxic glucose hypercatabolism in vivo has 
been documented, no attempts have been made to characterize 
it or define which peripheral t~ssues contribute to it. The 
results of an in vitro study (Table 6) evaluating glucose ox-
idation by ten endotoxic tissues presented here represent the 
first systematic assessment of specific tissue contributions 
to in vivo glucose hypercatabolism. 
A few studies have examined glucose uptake and oxidation 
by shock tissues, using other shock models. The epididymal 
fat pad from a rat peritonitis model (52) demonstrated ~lucose 
hypercatabolism; diaphragms removed from the same rat perito-
nitis model demonstrated no hypercatabolism, but demonstrated 
enhanced glucose uptake when removed from hemorrhaged rats (15). 
Such dita is inconclusive, since different models were utilized. 
The advantage of the studies pursued here li~s not only in the 
number of tissues studied, but also in the consistency of the 
endotoxic model used: all ten tissues were removed from each 
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rat administered endotoxin. Demonstration of a significant 
glucose hypercatabolism by epididymal fat pad and hemidiaphragm 
is in general agreement with the studies cited above. Although 
the liver is generally not considered a "peripheral" tissue, 
its glucose hypercatabolism is significant in view of its cen-
tral role in glucose metabolism and carbohydrate homeostasis. 
In particular, glucose consumption by the liver Kupffer cells 
: 
involved in the phagocytosis of endotoxin may be significant-
ly enhanced; demonstration of glucose hypercatabolism by the 
endotoxic liver may serve as a starting point for further in-
vestigations into liver--endotoxin interactions. The signi-
ficance of glucose hypercatabolism by the spleen has yet to 
be explored. 
It is interesting to note that the insulin-like action 
of endotoxin ~on peripheral tissue glucose oxidation is exerted 
on the three tissues noted for their sensitivity to insulin: 
the liver, muscle, and adipose. Hyperinsulinemia in the endo-
toxic animal has been reported; however, the missing links 
between administration of endotoxin, development of hyperin-
sulinemia, and derangements in carbohydrate homeostasis have 
not been found. In an attempt to clarify these phenomena some-
what, further in vitro studies were undertaken to evaluate the 
responsivity of endotoxic tis~ue to insulinL and to test the 
responsivity of normal rat tissue to endotoxin in vitro. 
Lack of in vitro Effect o£ Endotoxin on Fat Pad Glucose 
Oxidation 
The ability of endotoxin to directly affect tissue meta-
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bolism has been tested by a number of investigators. For in-
stance, Rush and Hsieh (51) evaluated oxygen consumption in 
canine liver slices · and reported that in vitro addition of en-
dotoxin had no significant effect on oxygen consumption, but 
liver slices from endotoxic dogs demonstrated a depressed oxy-
gen consumption. That. the endotoxin-induced derangements in 
carbohydrate metabolism are mediated rather.than direct has 
also been suggested by Moore, Goodrum, and Berry (45) in their 
study on endotoxic inhibition of PEPCK induction. These stu-
dies are in agreement with results presented here on epididy-
mal fat pad glucose oxidation (Table 8). In vitro addition 
of endotoxin in concentrations up to 200 ~g./ml. did not in-
fluence glucose oxidation, while epididymal fat pads removed 
from rats administered 0.75 mg. of endotoxin demonstrated a 
marked hypercatabolism. 
The results obtained in these studies, however, are in 
contrast to those of He'i.vlett et al. (2 8) in which rat epididy-
mal f~t cells were able, first, to respond to endotoxin direct-
ly by increasing their cAMP levels, and second, to alter their 
sertsitivity to epinephrine added to the incubation medium. 
Spitzer's demonstration (60) of a1tered sensitivity to nor-
epinephrine by isolated fat cells placed in a medium contain-
ing endotoxin also is in opposition to results presented here. 
Not only is the in vitro responsivity to endotoxin in oppo-
sition to the data presented here, but the concept of endo-
toxin raising cAMP levels is in contrast to the concept of its 
insulin-like nature described here; i.e., one would anticipate 
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that in vitro endotoxin would lov1er cAHP levels in adipose. 
If all of the above results were to be considered to-
gether, it would seem reasonable to conclude tha.t endotoxin's 
insulin-like stimulation of glucose oxidation is not due to 
a direct interaction with peripheral tissues. The only direct 
effects which have demonstrated to date cannot be considered 
"insulin-like". This leads to' the possibility that insulin 
itself mediates endotoxic glucose hypercatabolism, and thus 
the in vitro hypercatabolism demonstrated by endotoxic fat 
pads is due to the fact that while they were within the endo-
toxic rat, they were exposed to a higher "environment" of in-
sulin than the normal fat pad. 
In vivo arid in vitro Dexamethasone Prevention of Fat Pad 
Glucose Hypercatabolism 
The significant blunting of in vivo glucose hypercata-
bolism by administration of dexamethasone was demonstrated 
in vitro in the epididymat fat pad (Table 7 and Figure 5) • 
The data serves as an in vitro confirmation of glucocorti-
coid inhibition of glucose oxidation as an important mechanism 
underlying its protective effects as outlined above. No sig-
nificant influence was exerted by dexamethasone administra-
tion to untreated rats on fat pad glucose oxidation; dexa-
methasone did not suppress basal glucose uptake and utiliza-
tion. The latter results do conflict with in vitro studies 
by Czech and Fain (13) which demonstrated dexamethasone's 
ability to inhibit glucose oxidation in the presence and ab-
sence of insulin when glucose transport is rate-limiting; in 
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addition, Fain (18) proposed that a unique uptake process ex-
ists for glucose uptale by the adipocyte which is independent 
of insulin, but can be suppressed by dexamethasone. Although 
Czech and Fain based their glucose transport model on in Vitro 
glucocorticoid effects~ it seems reasonable to expect that en-
dogenous adrenal glucocorticoids or glucqcocrticoids administered 
in vivo would exert their influence by mechanisms similar to 
those elucidated in vitro. Data obtained here does not sup~ 
port the concept of glucocorticoid-induced suppression of ba-
sal glucose uptake and utilization by adipose tissue. 
~ vitro addition of dexamethasone at several dosages 
to the incubation medium (Table 9 and Figure 6) gave results 
which confirmed those obtained with in vivo administration 
of dexamethasone. Endotoxic glucose hypercatabolism was blunt-
ed by in vitro addition of dexamethasone in concentrations of 
100 or 200 ~g./ml. These results can be considered with other 
protective mechanisms of the glucocorticoids which have been 
demonstrated in an in vitro system: lysosomal membrane sta-
bilization (20) and decreased complement-fixation by endo-
toxin (56), and emphasize the ability of glucqcorticoids io 
exert their protective effects through direct interactions with 
endotoxic tissues. 
Studies of in vitro dexamethasone influence over glucose 
oxidation by fat pads from control animals provide evidence 
confl~cting with the work of Czech and Fain. In doses up to 
200 ~g./ml. within the incubation medium, dexamethasone did 
not suppress glucose oxidation. This is in direct contrast 
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to the in vitro results of Fain which were obtained using much 
smaller doses of dexamethasone. 
In vitro results obtained with endotoxic fat pads are 
in agreement with the postulate of Czech and Fain that dexa-
methasone can inhibit (insulin) stimulated glucose uptake, and 
provide a direct demonstration of a protective mechanism of 
the glucocorticoids in maintaining caloric homeostasis. 
Insulin Influence over Fat Pad Glucose Oxidation 
-Based on the documentation of endotoxic hyperinsulin-
emia, and 'the alterations in the sensitivity of adipose to 
norepinephrine and epinephrine, in vitro studies were carried 
out to evaluate the influence of high levels .of insulin on 
endotoxic fat pad glucose oxidation. 
In . vitro addition of insulin to the medium of control 
fat pads stimulated glucose oxidation at all doses used (Ta-
ble 10 and Figures 7 and· 8). Insulin addition to endotoxic 
fat pads significantly stimulated glucose oxidation although 
the fat pads were already hypercatabolic. Endotoxic fat pads 
did not exhibit altered sensitivity to insulin. Insulin en-
hanced glucose oxidation approximately three-fold in the nor-
mal fat pad as well as in the endotoxic fat pad at the doses 
employed. However, owing to the intrinsically higher rate of 
glucose utilization by the endotoxic fat pad, insulin enhance-
ment appeared to be much greater. 
These studies do not rule out the possibility that an 
altered sensitivity to insulin is manifest by endotoxic adi-
pocytes; rather, such an alteration seems reasonable in light 
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of the facts that, first altered sensitivity to another her-
mane has been demonstrated, and, second, that endotoxin ad-
ministration induces lipolysis. A significant reduction in 
fat content within the adipocyte may result in a significant 
reduction in size. An inverse relationship between cell size 
and hormone sensitivity has been documented by Storck and 
Spitzer for norepinephrine-stimulated lipolysis (66). Thus 
the hypothesis that endotoxic adipose exhibits altered sen-
sitivity to insulin seems tenable and another in vitro ap-
preach to the problem may be warranted. 
In vitro manipulations with adipocyte responsivity to 
insulin were attempted in the endotoxic animal in order to 
demonstrate that insulin is directly responsible for glu-
case hypercatabolism. Chang and Cuatrecasas (10) were able 
to demonstrate a reduction in the oxidative response of iso-
lated fat cells to insulin by the in vitro addition of ATP in 
concentrations of 10- 4 and 10~5 M to the incubation medium. 
' -5 At the concentration of 10 M, no influence on basal glucose 
uptake and oxidation was demonstrated. Glucose oxidation was 
inhibited when glucose transport served as a rate-limiting 
step. In the current studies, addition of ATP in concentrations 
-5 -4 
of 10 and 10 M to the medium of normal fat pads did not 
significantly alter their glucose oxidation (Table 11 and Fig-
ure 9). ATP addition in a concentration of 10- 4 M resulted 
in a significant depression of endotoxic glucose hypercatabo-
lism. If ATP-inhibition is specific for the insulin-mediated 
glucose transport p~oces~, then it seems reasonable to conclude 
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that endogenous insulin release is responsible for endotoxic 
glucose hypercatabolism. Inhibition of in vivo insulin release 
as would occur following administration of mannoheptulose in 
the endotoxic animal, foJlowed by in vitro evaluation of glu-
cose oxidation may provide a simple and direct test of the pos-
sibility that endotoxic peripheral tissue glucose hypercata-
holism occurs as a result of endogenous hyperinsulinemia. 
I 
Should such experimentation verify this hypothesis, then fur-
ther studies for the connections between endotoxin and the 
carbohydrate homeostasis derangements it causes would have to 
shift their focus to the pancreas and the mechanisms respon-
sible for endotoxin-induced insulin secretion. 
Ultimately, tissue glucose hypercatabolism is a phenom-
enon involving interactions--eg., insulin with its receptor--
at the cell membrane level. Figure 10 depicts possible in-
teractions occurring at the endotoxic adipocyte's membrane. 
Following administration of endotox{n, a hyperinsulinemia re-
sults. Insulin molecules can bind to their receptors, re-
sulting in an increased glucose uptake and oxidation. ATP in-
terferes with the stimulated glucose transport by phosphory-
lating the insulin receptor, as suggested by Chang and Cua-
t~ecasas (10). Dexameth~sone may blunt the enhanced glu-
cose uptake by one of two mechanisms: an immediate and direct 
interaction with the insulin receptor, or . possibly at another 
external membrane site; or by the well-characterized mech-
anism of action involving a lag period of one or two hours, 
and obligatory protein synthesis. Blunting of basal glucose 
uptake has not been demonstrated in these studies. 
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Conclusions 
In summary, the studies presented here have demonstrated: 
1. that protection against the development of hypoglycemia 
1s a significant mechanism underlying dexamethasone protection 
against endotoxic lethality. 
2. that endotoxic glucose hypercatabolism can be blunted 
both in vivo and in vitro by the administration of dexametha-
sone, thus protecting against the development of hypoglycemia. 
3. that liver, epididymal adipose, diaphragm, and spleen 
are tissues responsible for glucose hypercatabolism. 
4. that endotoxin does not exert its insulin-like actions 
on peripheral tissues through direct interactions, and 
5. that insulin--fat pad interactions may be responsible 
for endotoxic glucose hypercatabolism. 
FIGURE 10 
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